Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
50000,,23298033,CHEMBL4841419,Antibacterial activity against vancomycin-resistant Enterococcus NR 31909 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,4.0
50001,,23298034,CHEMBL4841420,Antibacterial activity against vancomycin-resistant Enterococcus NR 31912 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,4.0
50002,,23298035,CHEMBL4841421,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial load at 1X MIC preincubated for 6 hrs followed by subculturing on TSA plate for 18 to 20 hrs by time-kill assay,F,BAO_0000181,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,,3625513,=,1,0,=,Activity,log10CFU/ml,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,log10CFU/ml,,4.0
50003,,23298037,CHEMBL4841422,Antibiofilm activity against Staphylococcus aureus ATCC 29213 assessed as reduction in preformed bacterial biofilm at 1XMIC incubated for 24 hrs by crystal violet staining based microtiter plate reader assay,F,BAO_0000201,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://qudt.org/vocab/unit#Percent,3625513,=,1,1,=,Inhibition,%,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,%,UO_0000187,8.0
50004,,23298039,CHEMBL4841423,Antibiofilm activity against Staphylococcus aureus ATCC 29213 assessed as reduction in preformed bacterial biofilm at 10XMIC incubated for 24 hrs by crystal violet staining based microtiter plate reader assay,F,BAO_0000201,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://qudt.org/vocab/unit#Percent,3625513,=,1,1,=,Inhibition,%,30.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,%,UO_0000187,30.4
50005,,23298041,CHEMBL4841424,Antibacterial activity against Staphylococcus aureus ATCC 29213 infected in mouse J774.A1 assessed as reduction in intracellular bacterial burden at 5XMIC incubated for 24 hrs followed by replating on TSA plate for 24 hrs by intracellular killing assay,F,BAO_0000181,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,,3625513,=,1,0,=,Activity,log10CFU/ml,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,log10CFU/ml,,2.0
50006,,23298052,CHEMBL4841434,Synergistic antibacterial activity against multidrug-resistant methicillin resistant Staphylococcus aureus NRS 10119 assessed as reduction in bacterial load at 1X MIC preincubated for 24 hrs in presence of gentamycin followed by subculturing on TSA plate for 18 to 20 hrs by time-kill assay,F,BAO_0000181,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,,3625513,=,1,0,=,Activity,log10CFU/ml,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,log10CFU/ml,,6.0
50007,Active,23298053,CHEMBL4841435,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth at sub-MIC incubated for more than 40 days,F,BAO_0000375,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,,3625513,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
50008,,23298054,CHEMBL4841436,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial load at 10X MIC preincubated for 6 hrs followed by subculturing on TSA plate for 18 to 20 hrs by time-kill assay,F,BAO_0001103,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://qudt.org/vocab/unit#Percent,3625513,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
50009,,23298055,CHEMBL4841437,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial load at 10X MIC preincubated for 1 hr followed by subculturing on TSA plate for 18 to 20 hrs by time-kill assay,F,BAO_0000181,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,,3625513,=,1,0,=,Activity,log10CFU/ml,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,log10CFU/ml,,5.0
50010,,23298057,CHEMBL4841439,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition in presence of ceftazidime incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50011,,23298058,CHEMBL4841440,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition in presence of daptomycin incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50012,,23298059,CHEMBL4841441,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition in presence of gentamycin incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
50013,,23298060,CHEMBL4841442,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition in presence of levofloxacin incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50014,,23298061,CHEMBL4841443,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition in presence of linezolid incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50015,,23298062,CHEMBL4841444,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition in presence of meropenem incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50016,,23298063,CHEMBL4841445,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition in presence of minocycline incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50017,,23298064,CHEMBL4841446,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition in presence of rifampicin incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50018,,23298065,CHEMBL4841447,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition in presence of vancomycin incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625513,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50019,,23298066,CHEMBL4841448,Synergistic bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial load at 1X MIC preincubated for 6 hrs in presence of gentamycin followed by subculturing on TSA plate for 18 to 20 hrs by time-kill assay,F,BAO_0000181,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,,3625513,=,1,0,=,Activity,log10CFU/ml,9.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,log10CFU/ml,,9.0
50020,,23298067,CHEMBL4841449,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time for increase by 1 log10CFU at 1XMIC incubated for 1 hr followed by drug wash-out and measured every single 1 hr,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://qudt.org/vocab/unit#Hour,3625513,=,1,1,=,TIME,hr,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,4.0
50021,,23298070,CHEMBL4841450,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time for increase by 1 log10CFU at 10XMIC incubated for 1 hr followed by drug wash-out and measured every single 1 hr,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://qudt.org/vocab/unit#Hour,3625513,>,1,1,>,TIME,hr,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,24.0
50022,,23298073,CHEMBL4841451,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time for post-antibiotic effect at 1XMIC incubated for 1 hr followed by drug wash-out and measured every single 1 hr,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://qudt.org/vocab/unit#Hour,3625513,=,1,1,=,TIME,hr,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,2.0
50023,,23298076,CHEMBL4841452,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time for post-antibiotic effect at 10XMIC incubated for 1 hr followed by drug wash-out and measured every single 1 hr,F,BAO_0000179,BAO_0000218,organism-based format,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL485777,CUDRAFLAVONE C,CHEMBL485777,0,http://qudt.org/vocab/unit#Hour,3625513,>,1,1,>,TIME,hr,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,22.0
50024,,171387,CHEMBL799734,Compound was tested for the inhibition of Rev-RBE RNA complex formation,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1131109,J Med Chem,1998.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,88320,=,1,1,=,MIC,nM,1000.0,CHEMBL345,,Nucleic Acid,,,MIC,uM,UO_0000065,1.0
50025,,190699,CHEMBL767648,Tested for binding affinity against RNA construct A,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1135032,Bioorg Med Chem Lett,2002.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,232611,=,1,1,=,Kd,nM,410.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,0.41
50026,,190700,CHEMBL767650,Tested for binding affinity against RNA construct B,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1135032,Bioorg Med Chem Lett,2002.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,232611,=,1,1,=,Kd,nM,380.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,0.38
50027,,190701,CHEMBL767652,Tested for binding affinity against RNA construct C,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1135032,Bioorg Med Chem Lett,2002.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,232611,=,1,1,=,Kd,nM,4340.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,4.34
50028,,190702,CHEMBL767654,Tested for binding affinity against RNA construct D,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1135032,Bioorg Med Chem Lett,2002.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,232611,=,1,1,=,Kd,nM,470.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,0.47
50029,,190703,CHEMBL768316,Tested for binding affinity against RNA construct E,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1135032,Bioorg Med Chem Lett,2002.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,232611,=,1,1,=,Kd,nM,91.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,0.091
50030,,217837,CHEMBL803665,Compound was tested for inhibition against hammer head ribozyme complex (HH16-F),B,BAO_0000192,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1132019,Bioorg Med Chem Lett,1999.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,119686,=,1,1,=,Ki,nM,13500.0,CHEMBL612545,,Unchecked,,,Ki,uM,UO_0000065,13.5
50031,,393599,CHEMBL691409,Tested for the ability to bind the HIV-1 RRE-RNA construct by fluorescence anisotropy,F,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1134246,Bioorg Med Chem Lett,2001.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,14613,=,1,1,=,Kd,nM,180.0,CHEMBL3852,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 REV,11676.0,,Kd,uM,UO_0000065,0.18
50032,,473910,CHEMBL872745,Concentration required for the inhibition of HIV- 1 Tat-derived peptide binding to TAR RNA.,B,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1128082,Bioorg Med Chem Lett,1995.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,171466,=,1,1,=,IC50,nM,920.0,CHEMBL345,,Nucleic Acid,,,IC50,uM,UO_0000065,0.92
50033,,536094,CHEMBL615151,Dissociation constant towards 16S rRNA construct A,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1133237,Bioorg Med Chem Lett,2000.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,65946,=,1,1,=,Kd,nM,440.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,0.44
50034,,536095,CHEMBL615152,Dissociation constant towards 16S rRNA construct B,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1133237,Bioorg Med Chem Lett,2000.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,65946,=,1,1,=,Kd,nM,380.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,0.38
50035,,789042,CHEMBL729133,Dissociation constant for binding to mitochondrial 12S rRNA construct M2 was determined,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1135950,Bioorg Med Chem Lett,2002.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,128007,=,1,1,=,Kd,nM,140.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,0.14
50036,,789043,CHEMBL729134,Dissociation constant for binding to mitochondrial 12S rRNA construct M3 was determined,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1135950,Bioorg Med Chem Lett,2002.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,128007,=,1,1,=,Kd,nM,120.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,0.12
50037,,789044,CHEMBL729135,Dissociation constant for binding to mitochondrial 12S rRNA construct M4 was determined,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1135950,Bioorg Med Chem Lett,2002.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,128007,=,1,1,=,Kd,nM,160.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,0.16
50038,,789045,CHEMBL729136,Dissociation constant for binding to mitochondrial 12S rRNA construct M5 was determined,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1135950,Bioorg Med Chem Lett,2002.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,128007,=,1,1,=,Kd,nM,3970.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,3.97
50039,,809880,CHEMBL615150,Dissociation constant with dimeric 16S rRNA RNA construct B,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1133848,Bioorg Med Chem Lett,2001.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,189172,=,1,1,=,Kd,nM,350.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,0.35
50040,,936397,CHEMBL699214,Inhibitory activity of the aminoglycoside on Staphylococcus aureus IF-2 binding to fMet-tRNA(fMet),B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1145741,Bioorg Med Chem Lett,2003.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,349714,=,1,1,=,IC50,nM,50.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.05
50041,,936398,CHEMBL697161,Maximal inhibition of the aminoglycoside on Staphylococcus aureus IF-2 binding to fMet-tRNA(fMet),B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1145741,Bioorg Med Chem Lett,2003.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,349714,=,1,1,=,Inhibition,%,76.0,CHEMBL612545,,Unchecked,,,Inhibition,%,UO_0000187,76.0
50042,,936399,CHEMBL699213,Inhibitory activity against the displacement of Picogreen from fMet-tRNA(fMet) by the aminoglycoside,B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1145741,Bioorg Med Chem Lett,2003.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,349714,=,1,1,=,IC50,nM,9.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.009
50043,,936400,CHEMBL699215,Maximal inhibition against the displacement of Picogreen from fMet-tRNA(fMet) by the aminoglycoside,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1145741,Bioorg Med Chem Lett,2003.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,349714,=,1,1,=,Inhibition,%,100.0,CHEMBL612545,,Unchecked,,,Inhibition,%,UO_0000187,100.0
50044,,1040894,CHEMBL615153,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1133989,Bioorg Med Chem Lett,2001.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,25487,=,1,1,=,Kd,nM,19.0,CHEMBL614640,,Ribosomal RNA A-site,,,Kd,uM,UO_0000065,0.019
50045,,1446030,CHEMBL875732,Minimum inhibitory concentration required against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137173,Bioorg Med Chem Lett,2004.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,374291,=,1,1,=,MIC,nM,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.0
50046,,1446031,CHEMBL875733,Minimum inhibitory concentration required against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137173,Bioorg Med Chem Lett,2004.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,374291,=,1,1,=,MIC,nM,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,3.0
50047,,1446134,CHEMBL835550,Binding affinity towards decoding region at A-site of 16s rRNA,B,BAO_0000375,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137173,Bioorg Med Chem Lett,2004.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,374291,=,1,0,=,Activity,,-474.3,CHEMBL614640,,Ribosomal RNA A-site,,,Activity,,,-474.3
50048,,1462801,CHEMBL826981,Dissociation constant of the compound,P,BAO_0000034,BAO_0000100,small-molecule physicochemical format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1138674,J Med Chem,2004.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,378991,=,1,1,=,Kd,nM,100.0,CHEMBL2362975,,No relevant target,,,Kd,uM,UO_0000065,0.1
50049,,1462802,CHEMBL826981,Dissociation constant of the compound,P,BAO_0000034,BAO_0000100,small-molecule physicochemical format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1138674,J Med Chem,2004.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,378962,=,1,1,=,Kd,nM,1000.0,CHEMBL2362975,,No relevant target,,,Kd,uM,UO_0000065,1.0
50050,,1523290,CHEMBL826998,Binding dissociation constant towards 3'-Fl-AM1A-Rhd in Bacillus subtilis tyrS,F,BAO_0000034,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1143547,Bioorg Med Chem Lett,2005.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,395645,=,1,1,=,Kd,nM,8500.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Kd,uM,UO_0000065,8.5
50051,,1605039,CHEMBL881478,Effect against transactivation responsive RNA-binding protein at pH 7.4 (50 mM Tris-HCl and 20 M KCl) in fluorimetric competition assay,B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140393,Bioorg Med Chem Lett,2005.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,401466,=,1,1,=,IC50,nM,7000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,7.0
50052,,1605040,CHEMBL880591,"Effect towards transactivation responsive RNA-binding protein at pH 7.5, (10 mM Tris-HCl, 150 mM KCl)by using fluorimetric competition assay",B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140393,Bioorg Med Chem Lett,2005.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,401466,=,1,1,=,IC50,nM,35000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,35.0
50053,,1771112,CHEMBL856921,Inhibition of anthrax lethal factor metalloprotease,B,BAO_0000192,BAO_0000357,single protein format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1146910,Bioorg Med Chem Lett,2006.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,559074,=,1,1,=,Ki,nM,500.0,CHEMBL4372,Bacillus anthracis,Anthrax lethal factor,1392.0,,Ki app,uM,UO_0000065,0.5
50054,,1771192,CHEMBL909702,Binding affinity to Rev response element RNA,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1149371,Bioorg Med Chem Lett,2006.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,571563,=,1,1,=,Kd,nM,180.0,CHEMBL613297,Human immunodeficiency virus 1,Rev responsive element (RRE) RNA,11676.0,,Kd,uM,UO_0000065,0.18
50055,,1771194,CHEMBL909703,Binding affinity to tRNA,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1149371,Bioorg Med Chem Lett,2006.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,571563,=,1,1,=,Kd,nM,370.0,CHEMBL613297,Human immunodeficiency virus 1,Rev responsive element (RRE) RNA,11676.0,,Kd,uM,UO_0000065,0.37
50056,,1771254,CHEMBL909704,"Discrimination factor, Kd for tRNA/Kd for Rev response element RNA",B,BAO_0000193,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1149371,Bioorg Med Chem Lett,2006.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,571563,=,1,0,=,Ratio,,2.1,CHEMBL613297,Human immunodeficiency virus 1,Rev responsive element (RRE) RNA,11676.0,,Ratio,,,2.1
50057,,1804664,CHEMBL910461,Antibacterial activity against Escherichia coli W3110,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1138862,J Med Chem,2006.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Millimeter,620827,=,1,1,=,IZ,mm,15.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,15.0
50058,,1804770,CHEMBL910462,Antibacterial activity against Escherichia coli pTMV19,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1138862,J Med Chem,2006.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Millimeter,620827,=,1,1,=,IZ,mm,18.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,18.0
50059,,1804818,CHEMBL910463,Antibacterial activity against Escherichia coli pTMV19 in presence of mevalonate,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1138862,J Med Chem,2006.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Millimeter,620827,=,1,1,=,IZ,mm,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,12.0
50060,,1828246,CHEMBL908667,Antimicrobial activity against recombinant Escherichia coli DH5alpha expressing pBAD,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142159,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625709,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.5
50061,,1828254,CHEMBL908668,Antimicrobial activity against recombinant Escherichia coli DH5-alpha expressing pBAD in the presence of arabinose,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142159,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625709,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.5
50062,,1828261,CHEMBL908669,Antimicrobial activity against recombinant Escherichia coli DHalpha expressing pBAD [aph(3')-2],F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142159,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625709,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.5
50063,,1828268,CHEMBL908670,Antimicrobial activity against recombinant Escherichia coli DH5-alpha expressing pBAD [aph(3')-2] in the presence of arabinose,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142159,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625709,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,64.0
50064,,1828275,CHEMBL908671,Antimicrobial activity against Stenotrophomonas maltophilia K279a mutant,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142159,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625709,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,mg/L,UO_0000274,512.0
50065,,1828282,CHEMBL908672,Antimicrobial activity against Stenotrophomonas maltophilia K279a (aph FS) mutant,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142159,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625709,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,mg/L,UO_0000274,64.0
50066,,1829730,CHEMBL910826,Antimicrobial activity against Bifidobacterium animalis ATCC 27536,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,250.0
50067,,1829732,CHEMBL910827,Antimicrobial activity against Bifidobacterium bifidum R0071,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,250.0
50068,,1829734,CHEMBL910828,Antimicrobial activity against Bifidobacterium bifidum ATCC 15696,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,250.0
50069,,1829738,CHEMBL910830,Antimicrobial activity against Bifidobacterium breve ATCC 15700,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,250.0
50070,,1829740,CHEMBL910831,Antimicrobial activity against Bifidobacterium infantis ATCC 15697,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,250.0
50071,,1829742,CHEMBL911484,Antimicrobial activity against Bifidobacterium longum ATCC 15707,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,250.0
50072,,1829744,CHEMBL910832,Antimicrobial activity against Bifidobacterium longum ATCC 15708,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,250.0
50073,,1829746,CHEMBL910833,Antimicrobial activity against Bifidobacterium longum R0175,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,250.0
50074,,1829748,CHEMBL910834,Antimicrobial activity against Bifidobacterium longum P/N 601377,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,125.0
50075,,1829750,CHEMBL910835,Antimicrobial activity against Bifidobacterium pseudolongum ATCC 25562,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,250.0
50076,,1829752,CHEMBL910836,Antimicrobial activity against Bifidobacterium thermophilum ATCC 25866,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL614752,Bifidobacterium thermophilum,Bifidobacterium thermophilum,33905.0,,MIC,ug ml-1,UO_0000274,250.0
50077,,1829754,CHEMBL910837,Antimicrobial activity against Bifidobacterium breve R0070,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,250.0
50078,,1829756,CHEMBL910829,Antimicrobial activity against Bifidobacterium bifidum BB12,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,250.0
50079,,1830069,CHEMBL910838,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium animalis ATCC 27536 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,250.0
50080,,1830071,CHEMBL910839,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium bifidum R0071 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,250.0
50081,,1830073,CHEMBL910840,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium bifidum BB12 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,125.0
50082,,1830075,CHEMBL910841,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium breve ATCC 15700 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,125.0
50083,,1830077,CHEMBL910842,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium breve R0070 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,250.0
50084,,1830079,CHEMBL910843,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium infantis ATCC 15697 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,250.0
50085,,1830081,CHEMBL910844,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium longum ATCC 15707 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,500.0
50086,,1830083,CHEMBL910845,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium longum R0175 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,250.0
50087,,1830085,CHEMBL910846,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium longum P/N 601377 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,250.0
50088,,1830087,CHEMBL910847,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium pseudolongum ATCC 25562 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,250.0
50089,,1830089,CHEMBL910848,Antimicrobial activity against 60 min 1 M HCl-stressed Bifidobacterium thermophilum ATCC 25866 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL614752,Bifidobacterium thermophilum,Bifidobacterium thermophilum,33905.0,,MIC,ug ml-1,UO_0000274,250.0
50090,,1830330,CHEMBL910849,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium animalis ATCC 27536 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,125.0
50091,,1830338,CHEMBL910850,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium bifidum R0071 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,62.5,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,62.5
50092,,1830346,CHEMBL910851,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium bifidum ATCC 15696 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,250.0
50093,,1830354,CHEMBL910852,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium bifidum BB12 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,250.0
50094,,1830362,CHEMBL910853,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium breve ATCC 15700 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,125.0
50095,,1830370,CHEMBL910854,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium breve R0070 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,62.5,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,62.5
50096,,1830378,CHEMBL910855,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium infantis ATCC 15697 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,500.0
50097,,1830386,CHEMBL910856,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum ATCC 15707 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,125.0
50098,,1830394,CHEMBL910857,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum ATCC 15708 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,500.0
50099,,1830402,CHEMBL912625,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum R0175 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,62.5,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,62.5
50100,,1830410,CHEMBL912626,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium longum P/N 601377 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,62.5,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,62.5
50101,,1830418,CHEMBL912627,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium pseudolongum ATCC 25562 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,250.0
50102,,1830426,CHEMBL912628,Antimicrobial activity against 90 mins oxgall-stressed Bifidobacterium thermophilum ATCC 25866 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL614752,Bifidobacterium thermophilum,Bifidobacterium thermophilum,33905.0,,MIC,ug ml-1,UO_0000274,125.0
50103,,1830786,CHEMBL912629,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium animalis ATCC 27536 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,500.0
50104,,1830790,CHEMBL912630,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium bifidum R0071 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,125.0
50105,,1830793,CHEMBL912631,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium bifidum BB12 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,250.0
50106,,1830797,CHEMBL912632,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium breve ATCC 15700 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,250.0
50107,,1830801,CHEMBL912633,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium breve R0070 after 18 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,250.0
50108,,1830805,CHEMBL912634,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum ATCC 15707 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,250.0
50109,,1830809,CHEMBL912635,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum ATCC 15708 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,250.0
50110,,1830814,CHEMBL912636,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum R0175 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,125.0
50111,,1830818,CHEMBL912637,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium longum P/N 601377 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,125.0
50112,,1830822,CHEMBL912638,Antimicrobial activity against 90 mins hydrogen peroxide-stressed Bifidobacterium thermophilum ATCC 25866 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142148,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625638,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL614752,Bifidobacterium thermophilum,Bifidobacterium thermophilum,33905.0,,MIC,ug ml-1,UO_0000274,500.0
50113,,1834429,CHEMBL908676,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142160,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625715,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
50114,,1834434,CHEMBL908674,Antibacterial activity against Escherichia coli BL21(DE3),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142160,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625715,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,12.0
50115,,1834439,CHEMBL908677,Antibacterial activity against Escherichia coli BL21(DE3) expressing Pseudomonas aeruginosa APH(3')-2b,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142160,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625715,=,1,1,=,MIC,ug.mL-1,96.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,96.0
50116,,1834443,CHEMBL908675,Activity against Pseudomonas aeruginosa APH(3')-2b expressed in Escherichia coli BL21(DE3) assessed as phosphorylation,B,BAO_0000477,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142160,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,625715,=,1,1,=,Km,nM,17500.0,CHEMBL1075212,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG12228),Aminoglycoside 3'-phosphotransferase type IIb,208964.0,,Km,uM,UO_0000065,17.5
50117,,1835338,CHEMBL908673,Ratio of km to kcat for PH(3')-2b activity,B,BAO_0000179,BAO_0000357,single protein format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142160,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,625715,=,1,0,=,Kcat/Km,/M/s,120000.0,CHEMBL1075212,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG12228),Aminoglycoside 3'-phosphotransferase type IIb,208964.0,,Kcat/Km,/M/s,,120000.0
50118,,1847777,CHEMBL920568,Antimicrobial activity against Pseudomonas aeruginosa PA0905,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142071,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632045,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
50119,,1847782,CHEMBL920569,Antimicrobial activity against Escherichia coli XL1-Blue pPA95S29,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142071,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632045,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
50120,,1847787,CHEMBL920570,Antimicrobial activity against Escherichia coli XL1-Blue [pBluescript 2 SK(+),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1142071,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632045,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
50121,,1878577,CHEMBL905587,Ototoxicity assessed as cochlear inner cells damage in Albino guinea pig with transtympanic application in right ear relative to left ear control,T,BAO_0001103,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1143047,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,637722,=,1,0,=,Activity,%,0.0,CHEMBL369,Cavia porcellus,Cavia porcellus,10141.0,,Activity,%,UO_0000187,0.0
50122,,1878578,CHEMBL905588,Ototoxicity assessed as cochlear outer cells damage in Albino guinea pig with transtympanic application in right ear relative to left ear control,T,BAO_0001103,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1143047,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,637722,=,1,0,=,Activity,%,100.0,CHEMBL369,Cavia porcellus,Cavia porcellus,10141.0,,Activity,%,UO_0000187,100.0
50123,,1878579,CHEMBL905589,Ototoxicity assessed as vestibular damage in Albino guinea pig with transtympanic application in right ear relative to left ear control,T,BAO_0001103,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1143047,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,637722,=,1,0,=,Activity,%,50.0,CHEMBL369,Cavia porcellus,Cavia porcellus,10141.0,,Activity,%,UO_0000187,50.0
50124,Active,1878601,CHEMBL905590,Antimicrobial activity against Micrococcus luteus ATCC 9341 at 15 mg/ml after 24 hrs by micro dilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1143047,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,637722,,1,0,,Activity,,,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,Activity,,,
50125,Active,1878602,CHEMBL905591,Antimicrobial activity against Staphylococcus aureus ATCC 6538 at 15 mg/ml after 24 hrs by micro dilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1143047,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,637722,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
50126,Active,1878603,CHEMBL905592,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 at 15 mg/ml after 24 hrs by micro dilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1143047,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,637722,,1,0,,Activity,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,,,
50127,Active,1878604,CHEMBL905593,Antimicrobial activity against Escherichia coli ATCC 25922 at 15 mg/ml after 24 hrs by micro dilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1143047,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,637722,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
50128,Active,1878605,CHEMBL905594,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 at 15 mg/ml after 24 hrs by micro dilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1143047,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,637722,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
50129,,1988840,CHEMBL899012,Binding affinity to Escherichia coli K12 stem-loop region L2-10 RNA aptamers using luminescence spectrometer by anisotropy technique,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137519,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,663443,=,1,1,=,Kd,nM,308.0,CHEMBL612545,,Unchecked,,,Kd,nM,UO_0000065,308.0
50130,,1988842,CHEMBL899013,Binding affinity to Escherichia coli K12 stem-loop region L2-11 RNA aptamers using luminescence spectrometer by anisotropy technique,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137519,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,663443,=,1,1,=,Kd,nM,313.0,CHEMBL612545,,Unchecked,,,Kd,nM,UO_0000065,313.0
50131,,1988844,CHEMBL899014,Binding affinity to Escherichia coli K12 stem-loop region L2-12 RNA aptamers using luminescence spectrometer by anisotropy technique,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137519,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,663443,=,1,1,=,Kd,nM,320.0,CHEMBL612545,,Unchecked,,,Kd,nM,UO_0000065,320.0
50132,,1988846,CHEMBL899016,Binding affinity to Escherichia coli K12 stem-loop region L2-11 RNA aptamers using BIAcore 3000 instrument,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137519,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,663443,=,1,1,=,Kd,nM,6300.0,CHEMBL612545,,Unchecked,,,Kd,10^-6/M,UO_0000065,6.3
50133,,1988848,CHEMBL899015,Binding affinity to Escherichia coli K12 stem-loop region L2-12 RNA aptamers using BIAcore 3000 instrument,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137519,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,663443,=,1,1,=,Kd,nM,2300.0,CHEMBL612545,,Unchecked,,,Kd,10^-6/M,UO_0000065,2.3
50134,,1988983,CHEMBL899044,Antibacterial activity against Escherichia coli ATCC 25922 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137524,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663491,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50135,,1988991,CHEMBL899045,Antibacterial activity against aminoglycoside-susceptible Escherichia coli TG1 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137524,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663491,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50136,,1988999,CHEMBL899043,Antibacterial activity against aminoglycoside-resistant Escherichia coli TG1 pSF815 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137524,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663491,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50137,,1989007,CHEMBL899046,Antibacterial activity against aminoglycoside-resistant Escherichia coli TG1 pTZ19U-3 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137524,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663491,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
50138,,1989015,CHEMBL899047,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137524,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663491,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
50139,,1989020,CHEMBL899048,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137524,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663491,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
50140,,1989025,CHEMBL899049,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137524,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663491,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
50141,,1989030,CHEMBL899050,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1137524,Bioorg Med Chem,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663491,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
50142,,2197648,CHEMBL947707,Antibacterial activity against Staphylococcus aureus at 30 ug after overnight incubation by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1155740,J Nat Prod,2001.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Millimeter,741148,=,1,1,=,IZ,mm,9.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,9.0
50143,,2215705,CHEMBL969335,Binding affinity to T box antiterminator RNA AM1A by FRET,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1149873,Bioorg Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,768224,=,1,1,=,Kd,nM,8000.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,8.0
50144,Active,2215706,CHEMBL969333,Induction of tRNA-UCCA binding to T box antiterminator RNA AM1A at 200 uM by FRET method,B,BAO_0000375,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1149873,Bioorg Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,768224,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
50145,,2215707,CHEMBL969334,Binding affinity to T box antiterminator RNA,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1149873,Bioorg Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,768224,=,1,1,=,Kd,nM,8000.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,8.0
50146,,2278291,CHEMBL1022391,Antibacterial activity against kanamycin-resistant Escherichia coli AG100B expressing aminoglycosides resistant APH(3')-1 enzyme by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,384.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,384.0
50147,,2278310,CHEMBL1022392,Antibacterial activity against kanamycin-resistant Escherichia coli AG100A expressing aminoglycosides resistant APH(3')-1 enzyme by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,96.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,96.0
50148,,2278329,CHEMBL1022393,Antibacterial activity against aminoglycosides-susceptible Bacillus subtilis ATCC 6633 by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.5
50149,,2278348,CHEMBL1022394,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,384.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,384.0
50150,,2278367,CHEMBL1022395,Antibacterial activity against Escherichia coli XL1-blue by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.0
50151,,2278374,CHEMBL1022396,Antibacterial activity against aminoglycosides-resistant Escherichia coli XL1-blue harboring pSF815 expressing AAC(6')-APH(2'') enzyme by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,>,1,1,>,MIC,ug.mL-1,384.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,384.0
50152,,2278381,CHEMBL1022397,"Resistance index, MIC for aminoglycosides-resistant Escherichia coli XL1-blue harboring pSF815 expressing AAC(6')-APH(2'') enzyme to MIC for Escherichia coli XL1-blue",F,BAO_0000193,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,754507,>,1,0,>,Ratio,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,64.0
50153,,2278388,CHEMBL1022398,Antibacterial activity against aminoglycosides-resistant Escherichia coli XL1-blue harboring pET9d expressing APH(3')-1a enzyme by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,96.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,96.0
50154,,2278395,CHEMBL1022399,"Resistance index, MIC for aminoglycosides-resistant Escherichia coli XL1-blue harboring pET9d expressing APH(3')-1a enzyme to MIC for Escherichia coli XL1-blue",F,BAO_0000193,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,754507,=,1,0,=,Ratio,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,16.0
50155,,2278402,CHEMBL1022400,Antibacterial activity against Escherichia coli BL21 by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.0
50156,,2278409,CHEMBL1022401,Antibacterial activity against aminoglycosides-resistant Escherichia coli BL21 harboring pETSACG1 expressing APH(3')-3a enzyme by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,48.0
50157,,2278416,CHEMBL1022402,"Resistance index, MIC for aminoglycosides-resistant Escherichia coli BL21 harboring pETSACG1 expressing APH(3')-3a enzyme to MIC for Escherichia coli BL21",F,BAO_0000193,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,754507,=,1,0,=,Ratio,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,8.0
50158,Not Active,2278426,CHEMBL1022405,Inhibition of Escherichia coli DNA gyrase assessed as reduction in relaxed pBR322 DNA supercoiling activity after 1 hr by electrophoresis,B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,754507,,1,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50159,Not Active,2278431,CHEMBL1022406,Inhibition of Escherichia coli topoisomerase 4 assessed as reduction in supercoiled pBR322 DNA relaxation activity after 30 mins by electrophoresis,B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,754507,,1,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50160,,2278436,CHEMBL1022407,Inhibition of protein synthesis in Escherichia coli S30 extracts assessed as luciferase activity after 1 hr by coupled transcription/translation assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,754507,=,1,1,=,IC50,nM,10500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,uM,UO_0000065,10.5
50161,,2278440,CHEMBL1022403,Activity at aminoglycoside 3'-phosphotransferase 3a,B,BAO_0000481,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,754507,=,1,0,=,Kcat,/s,2.4,CHEMBL612545,,Unchecked,,,Kcat,/s,,2.4
50162,,2278441,CHEMBL1022404,Ratio of kcat/km for aminoglycoside 3'-phosphotransferase 3a,B,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,754507,=,1,0,=,Kcat/Km,10'-4/M/s,42.0,CHEMBL612545,,Unchecked,,,Kcat/Km,10'-4/M/s,,42.0
50163,,2281753,CHEMBL1022403,Activity at aminoglycoside 3'-phosphotransferase 3a,B,BAO_0000477,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,754507,=,1,1,=,Km,nM,5700.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,5.7
50164,,2281755,CHEMBL1022389,Antibacterial activity against Escherichia coli R477-100 by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,24.0
50165,,2281774,CHEMBL1022390,Antibacterial activity against Escherichia coli ATCC 25922 by double-microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1153403,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,754507,=,1,1,=,MIC,ug.mL-1,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,48.0
50166,,2362547,CHEMBL1034850,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140095,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,747919,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50167,,2362548,CHEMBL1034851,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140095,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,747919,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
50168,,2362549,CHEMBL1034852,Antibacterial activity against Staphylococcus epidermidis ATCC 1490 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140095,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,747919,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
50169,,2362550,CHEMBL1034853,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 14990 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140095,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,747919,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
50170,,2362551,CHEMBL1034854,Antibacterial activity against methicillin-resistant Streptococcus pneumoniae ATCC 49619 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140095,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,747919,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
50171,,2362552,CHEMBL1034855,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140095,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,747919,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
50172,,2362553,CHEMBL1034856,Antibacterial activity against gentamicin-resistant Escherichia coli ATCC 6174 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140095,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,747919,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50173,,2362554,CHEMBL1034857,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140095,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,747919,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,512.0
50174,,2362603,CHEMBL1034858,Antibacterial activity against Candida albicans,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140095,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,747919,>=,1,1,>=,MIC,ug.mL-1,512.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,512.0
50175,,2384207,CHEMBL999336,Antibacterial activity against aminoglycoside-susceptible Escherichia coli ATCC 25922 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50176,,2384218,CHEMBL999337,Antibacterial activity against aminoglycoside-susceptible Staphylococcus aureus ATCC 25923 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50177,,2384246,CHEMBL999338,Antibacterial activity against aminoglycoside-susceptible Escherichia coli TG1 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50178,,2384274,CHEMBL999339,Antibacterial activity against Escherichia coli TG1 pSF815 plasmid encoded for AAC(6')/APH(2') after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50179,,2384302,CHEMBL999340,Antibacterial activity against Escherichia coli TG1 pTZ19U-3 plasmid encoded for APH(3')-1 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,>=,1,1,>=,MIC,ug.mL-1,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2000.0
50180,,2384332,CHEMBL999341,Activity of Enterococcus APH(3')-3a,B,BAO_0000477,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,803022,=,1,1,=,Km,nM,6000.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,6.0
50181,,2384390,CHEMBL999341,Activity of Enterococcus APH(3')-3a,B,BAO_0000481,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,803022,=,1,0,=,Kcat,/s,1.61,CHEMBL612545,,Unchecked,,,Kcat,/s,,1.61
50182,,2384419,CHEMBL999342,Ratio of kcat to Km of Enterococcus APH(3')-3a,B,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,803022,=,1,0,=,Kcat/Km,10'4/M/s,26.8,CHEMBL612545,,Unchecked,,,Kcat/Km,10'4/M/s,,26.8
50183,,2384448,CHEMBL999343,Antibacterial activity against Escherichia coli TG1 pET28a plasmid encoded for APH(3')-3a after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
50184,,2384477,CHEMBL999344,Ratio of MIC for Escherichia coli TG1 to MIC for Escherichia coli TG1 pET28a plasmid encoded for APH(3')-3a,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
50185,,2384508,CHEMBL999345,Antibacterial activity against ampicillin-resistant and aminoglycosides-susceptible Klebsiella pneumoniae ATCC 13883 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
50186,,2384516,CHEMBL999346,Antibacterial activity against multidrug-resistant Klebsiella pneumoniae ATCC 700603 isolate after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
50187,,2384524,CHEMBL999347,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,125.0
50188,,2384532,CHEMBL999348,Antibacterial activity against aminoglycosides-resistant Pseudomonas aeruginosa ATCC 27853 expressing APH(3')-2b after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
50189,,2384540,CHEMBL999349,Antibacterial activity against vancomycin-susceptible and aminoglycosides-resistant Enterococcus faecalis ATCC 29212 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
50190,,2384548,CHEMBL999350,"Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 expressing vanB, ant(6)-1, aac(6')-aph(2') resistant gene after 12 to 18 hrs",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1140232,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,803022,>=,1,1,>=,MIC,ug.mL-1,250.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,250.0
50191,,2573375,CHEMBL984787,Inhibition of phospholipase C,B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1155111,J Med Chem,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,743545,=,1,1,=,IC50,nM,11000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,11.0
50192,,2624183,CHEMBL1007463,Binding affinity to A-site RNA,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1136940,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,757423,=,1,1,=,Kd,nM,60.0,CHEMBL345,,Nucleic Acid,,,Kd,nM,UO_0000065,60.0
50193,,2680230,CHEMBL1057970,Antibacterial activity against Escherichia coli isolate ARS3 carrying pARS3 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823379,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
50194,,2680247,CHEMBL1057971,Antibacterial activity against Escherichia coli CSH-2 carrying Escherichia coli ARS3 pARS3 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823379,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
50195,,2680635,CHEMBL1057972,Antibacterial activity against Escherichia coli CSH-2 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823379,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.13
50196,,2680652,CHEMBL1057973,Antibacterial activity against Escherichia coli JM109 carrying pMCL-BE by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823379,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
50197,,2680669,CHEMBL1057974,Antibacterial activity against Escherichia coli JM109 carrying pMCL210 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823379,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
50198,Active,2680680,CHEMBL1057977,Binding affinity to 16S rRNA G1494(N7) position in wild type Escherichia coli JM109 30S sunit at 100 uM by footprint assay,B,BAO_0000375,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,823379,,1,0,,Activity,,,CHEMBL345,,Nucleic Acid,,,Activity,,,
50199,Active,2680681,CHEMBL1057978,Binding affinity to 16S rRNA G1494(N7) position in wild type Escherichia coli JM109 30S sunit at 1000 uM by footprint assay,B,BAO_0000375,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,823379,,1,0,,Activity,,,CHEMBL345,,Nucleic Acid,,,Activity,,,
50200,Not Active,2680686,CHEMBL1057979,Binding affinity to 16S rRNA G1494(N7) position in A1408-methylated Escherichia coli JM109 30S sunit at 100 uM by footprint assay,B,BAO_0000375,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,823379,,1,0,,Activity,,,CHEMBL345,,Nucleic Acid,,,Activity,,,
50201,Not Active,2680687,CHEMBL1057980,Binding affinity to 16S rRNA G1494(N7) position in A1408-methylated Escherichia coli JM109 30S sunit at 1000 uM by footprint assay,B,BAO_0000375,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,823379,,1,0,,Activity,,,CHEMBL345,,Nucleic Acid,,,Activity,,,
50202,,2932474,CHEMBL1049390,Antibacterial activity against Klebsiella pneumoniae ATCC 700603,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1154782,J Med Chem,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,848277,=,1,1,=,IC50,ug.mL-1,0.6,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,IC50,ug ml-1,UO_0000274,0.6
50203,,2994511,CHEMBL1048037,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50204,,2994512,CHEMBL1048038,Antibacterial activity against NorA pump expressing Staphylococcus aureus after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50205,,2994513,CHEMBL1044326,Antibacterial activity against MsrA pump expressing Staphylococcus aureus after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50206,,2994514,CHEMBL1044327,Antibacterial activity against aminoglycoside-6'-N-acetyltransferase/2''-O-phosphoryltransferase expressing Staphylococcus aureus after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50207,,2994515,CHEMBL1044328,Antibacterial activity against aminoglycoside-3'-O-phosphoryltransferase expressing Staphylococcus aureus after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
50208,,2994516,CHEMBL1044329,Antibacterial activity against aminoglycoside-4'-O-phosphoryltransferase expressing Staphylococcus aureus after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
50209,,2994517,CHEMBL1044330,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 clinical isolate after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
50210,,2994518,CHEMBL1044331,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS-2 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
50211,,2995822,CHEMBL1044332,Antibacterial activity against Acinetobacter lwoffii ATCC 17925 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.5
50212,,2995823,CHEMBL1044333,Antibacterial activity against APH30-VIa expressing Acinetobacter lwoffii AI.88-483 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,128.0
50213,,2995824,CHEMBL1044334,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
50214,,2995825,CHEMBL1044335,Antibacterial activity against AAC6'-2a expressing Pseudomonas aeruginosa F03 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
50215,,2995826,CHEMBL1044336,Antibacterial activity against MexXY expressing Pseudomonas aeruginosa PT629 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
50216,,2995827,CHEMBL1046944,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
50217,,2995828,CHEMBL1046945,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
50218,,2995829,CHEMBL1046946,Antibacterial activity against AAC6'-2b expressing Escherichia coli PAZ505H8101 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50219,,2995830,CHEMBL1046947,Antibacterial activity against ANT2'-2a expressing Escherichia coli L58058.1 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
50220,,2995951,CHEMBL1046958,"Inhibition of protein synthesis in Pseudomonas aeruginosa ATCC 27853 assessed as decrease in incorporation of L-[4,5-3H]leucine at MIC by liquid scintillation counter relative to control",F,BAO_0000201,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,856634,=,1,1,=,Inhibition,%,40.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,40.0
50221,,2995952,CHEMBL1046959,"Inhibition of protein synthesis in Pseudomonas aeruginosa ATCC 27853 assessed as decrease in incorporation of L-[4,5-3H]leucine at 10 times MIC by liquid scintillation counter relative to control",F,BAO_0000201,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,856634,=,1,1,=,Inhibition,%,40.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,40.0
50222,,2995958,CHEMBL1046961,Binding affinity to bacterial rRNA A site at 200 uM by isothermal titration calorimetry,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,856634,=,1,1,=,Kd,nM,1550.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,1.55
50223,,2995959,CHEMBL1046948,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
50224,,2995960,CHEMBL1046949,Antibacterial activity against MexCD expressing Pseudomonas aeruginosa PA01 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
50225,,2995961,CHEMBL1046950,Antibacterial activity against MexEF expressing Pseudomonas aeruginosa PA03 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
50226,,2995962,CHEMBL1046951,Antibacterial activity against MexAB expressing Pseudomonas aeruginosa PA21 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
50227,,2995963,CHEMBL1046952,Antibacterial activity against MexXY expressing Pseudomonas aeruginosa PA22 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
50228,,2995964,CHEMBL1046953,"Antibacterial activity against TriABC expressing MexAB, MexCD, MexEF, MexXY deleted Pseudomonas aeruginosa PA405 after 24 hrs by geometric microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
50229,,2995965,CHEMBL1046954,"Antibacterial activity against MexAB, MexCD, MexEF, MexXY, TriABC deleted Pseudomonas aeruginosa PA406 after 24 hrs by geometric microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1156794,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856634,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
50230,,3114005,CHEMBL1073704,Antibacterial activity against aminoglycoside-susceptible Escherichia coli ATCC 25922 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1157553,Bioorg Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,888067,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50231,,3114007,CHEMBL1073705,Antibacterial activity against aminoglycoside-susceptible Staphylococcus aureus ATCC 25923 after 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1157553,Bioorg Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,888067,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50232,,3283491,CHEMBL1112950,Antibacterial activity against Streptococcus pneumoniae ATCC 13883 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
50233,,3283492,CHEMBL1112949,Antibacterial activity against Acinetobacter baumannii CAN-ICU 63169 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,64.0
50234,,3283493,CHEMBL1112948,Antibacterial activity against Stenotrophomonas maltophilia CAN-ICU 62585 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,512.0
50235,,3283494,CHEMBL1112947,Antibacterial activity against Pseudomonas aeruginosa CAN-ICU 62308 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,512.0
50236,,3283495,CHEMBL1112946,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,512.0
50237,Not Determined,3283496,CHEMBL1112945,Antibacterial activity against Escherichia coli CAN-ICU 63074 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,908908,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
50238,,3283497,CHEMBL1112943,Antibacterial activity against gentamicin-resistant Escherichia coli ATCC 6174 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
50239,,3283498,CHEMBL1112944,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50240,,3283499,CHEMBL1112942,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
50241,,3283500,CHEMBL1112941,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 14990 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
50242,,3283501,CHEMBL1112940,Antibacterial activity against Staphylococcus epidermidis ATCC 1490 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
50243,,3283502,CHEMBL1112939,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
50244,,3283503,CHEMBL1112938,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1158537,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,908908,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50245,,3404891,CHEMBL1219693,Dissociation constant Kd of the compound,P,BAO_0000034,BAO_0000100,small-molecule physicochemical format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1212899,J Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,932623,=,1,1,=,Kd,nM,2600.0,CHEMBL2362975,,No relevant target,,,Kd,uM,UO_0000065,2.6
50246,Active,3418425,CHEMBL1226169,"Binding affinity to phosphatidylinositol 4,5-bisphosphate liposome assessed as dynamin2-stimulated GTP hydrolysis at 250 uM by scintillation counting",B,BAO_0000375,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1221177,Nat Chem Biol,2006.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,935427,,1,0,,Activity,,,CHEMBL4651323,,Lipid bilayer,,,Activity,,,
50247,,3464170,CHEMBL1251792,Binding affinity to Escherichia coli 23S rRNA assessed as decrease in classical-state occupancy by tRNA at 20 uM by smFRET,B,BAO_0001103,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1250449,Nat Chem Biol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,955279,=,1,0,=,Activity,%,10.0,CHEMBL345,,Nucleic Acid,,,Activity,%,UO_0000187,10.0
50248,,3464171,CHEMBL1251795,Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as increase in classical-state occupancy by tRNA at 100 nM by smFRET,B,BAO_0001103,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1250449,Nat Chem Biol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,955279,=,1,0,=,Activity,%,6.0,CHEMBL345,,Nucleic Acid,,,Activity,%,UO_0000187,6.0
50249,,3464172,CHEMBL1251796,Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as decrease in classical-state occupancy by tRNA at 20 uM by smFRET,B,BAO_0001103,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1250449,Nat Chem Biol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,955279,=,1,0,=,Activity,%,10.0,CHEMBL345,,Nucleic Acid,,,Activity,%,UO_0000187,10.0
50250,,3464176,CHEMBL1251730,Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as reduction in rate of tRNA exit from classical state at 100 nM,B,BAO_0000179,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1250449,Nat Chem Biol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,955279,=,1,0,=,FC,,1.5,CHEMBL345,,Nucleic Acid,,,FC,,,1.5
50251,,3464177,CHEMBL1251731,Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as reduction in rate of tRNA translocation at 100 nM,B,BAO_0000179,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1250449,Nat Chem Biol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,955279,=,1,0,=,FC,,3.0,CHEMBL345,,Nucleic Acid,,,FC,,,3.0
50252,,3464191,CHEMBL1251741,Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as classical-state occupancy by tRNA at 100 nM (Rvb= 62.4+/-1.1%),B,BAO_0001103,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1250449,Nat Chem Biol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,955279,=,1,0,=,Activity,%,70.3,CHEMBL345,,Nucleic Acid,,,Activity,%,UO_0000187,70.3
50253,,3464192,CHEMBL1251742,Binding affinity to Escherichia coli 23S rRNA H69 assessed as classical-state occupancy by tRNA at 20 uM (Rvb= 62.4+/-1.1%),B,BAO_0001103,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1250449,Nat Chem Biol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,955279,=,1,0,=,Activity,%,52.0,CHEMBL345,,Nucleic Acid,,,Activity,%,UO_0000187,52.0
50254,,3464193,CHEMBL1251745,Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as tRNA translocation rate at 100 nM (Rvb= 1.57+/-0.05 /sec),B,BAO_0000181,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1250449,Nat Chem Biol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,955279,=,1,0,=,Activity,/s,0.31,CHEMBL345,,Nucleic Acid,,,Activity,/s,,0.31
50255,,3464195,CHEMBL1251746,Binding affinity to Escherichia coli 23S rRNA H69 assessed as tRNA translocation rate at 20 uM (Rvb= 1.57+/-0.05 /sec),B,BAO_0000181,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1250449,Nat Chem Biol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,955279,=,1,0,=,Activity,/s,0.06,CHEMBL345,,Nucleic Acid,,,Activity,/s,,0.06
50256,,3496567,CHEMBL1265431,Ratio of Kcat to Km for APH(3')-3a by PK/LDH-coupled assay in presence of ATP,B,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1255466,Antimicrob Agents Chemother,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,958005,=,1,0,=,Kcat/Km,10'5/s/M,1.5,CHEMBL612545,,Unchecked,,,Kcat/Km,10'5/s/M,,1.5
50257,,3496568,CHEMBL1265430,Activity at APH(3')-3a by PK/LDH-coupled assay in presence of ATP,B,BAO_0000481,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1255466,Antimicrob Agents Chemother,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,958005,=,1,0,=,Kcat,/s,1.59,CHEMBL612545,,Unchecked,,,Kcat,/s,,1.59
50258,,3496569,CHEMBL1265430,Activity at APH(3')-3a by PK/LDH-coupled assay in presence of ATP,B,BAO_0000477,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1255466,Antimicrob Agents Chemother,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,958005,=,1,1,=,Km,nM,10600.0,CHEMBL612545,,Unchecked,,,Km,uM,UO_0000065,10.6
50259,,3511091,CHEMBL1264324,Antimicrobial activity against amikacin-resistant Nocardia farcinica IFM 10580 after 3 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1255473,Antimicrob Agents Chemother,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958012,>,1,1,>,MIC,ug.mL-1,1024.0,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,MIC,ug ml-1,UO_0000274,1024.0
50260,,3511105,CHEMBL1264325,Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 harboring 16s rRNA A1408G mutant after 3 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1255473,Antimicrob Agents Chemother,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958012,>,1,1,>,MIC,ug.mL-1,1024.0,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,MIC,ug ml-1,UO_0000274,1024.0
50261,,3511119,CHEMBL1264326,Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 harboring 16s rRNA A1408G mutant after 5 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1255473,Antimicrob Agents Chemother,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958012,>,1,1,>,MIC,ug.mL-1,1024.0,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,MIC,ug ml-1,UO_0000274,1024.0
50262,,3511133,CHEMBL1264434,Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 after 3 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1255473,Antimicrob Agents Chemother,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958012,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,MIC,ug ml-1,UO_0000274,16.0
50263,,3531761,CHEMBL1284892,Antimicrobial activity against Clostridium sordellii by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,MIC90,ug ml-1,UO_0000274,1024.0
50264,,3531766,CHEMBL1284894,Antimicrobial activity against Clostridium sp. by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50265,,3531771,CHEMBL1284896,Antimicrobial activity against Clostridium spiroforme by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50266,,3531776,CHEMBL1284898,Antimicrobial activity against Clostridium sporogenes by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,MIC90,ug ml-1,UO_0000274,1024.0
50267,,3531781,CHEMBL1284900,Antimicrobial activity against Clostridium subterminale by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50268,,3531786,CHEMBL1285042,Antimicrobial activity against Clostridium symbiosum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50269,,3531791,CHEMBL1285044,Antimicrobial activity against Clostridium tertium by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC90,ug ml-1,UO_0000274,1024.0
50270,,3531796,CHEMBL1285046,Antimicrobial activity against Actinomyces meyeri by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,MIC90,ug ml-1,UO_0000274,1024.0
50271,,3531801,CHEMBL1285048,Antimicrobial activity against Actinomyces odontolyticus by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50272,,3531806,CHEMBL1285050,Antimicrobial activity against Actinomyces viscosus by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,MIC90,ug ml-1,UO_0000274,1024.0
50273,,3531811,CHEMBL1285052,Antimicrobial activity against Atopobium minutum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50274,,3531816,CHEMBL1285054,Antimicrobial activity against Bifidobacterium adolescentis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50275,,3531821,CHEMBL1285056,Antimicrobial activity against Bifidobacterium bifidum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC90,ug ml-1,UO_0000274,1024.0
50276,,3531826,CHEMBL1285058,Antimicrobial activity against Bifidobacterium breve by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC90,ug ml-1,UO_0000274,1024.0
50277,,3531831,CHEMBL1285060,Antimicrobial activity against Bifidobacterium dentium by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50278,,3531836,CHEMBL1285062,Antimicrobial activity against Bifidobacterium infantis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50279,,3531841,CHEMBL1285064,Antimicrobial activity against Bifidobacterium longum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC90,ug ml-1,UO_0000274,1024.0
50280,,3531846,CHEMBL1285066,Antimicrobial activity against Bifidobacterium pseudocatenulatum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50281,,3531851,CHEMBL1285068,Antimicrobial activity against Bifidobacterium pseudolongum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50282,,3531856,CHEMBL1285070,Antimicrobial activity against Catenibacterium mitsuokai by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50283,,3531861,CHEMBL1285072,Antimicrobial activity against Colinsella aerofaciens by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,MIC90,ug ml-1,UO_0000274,1024.0
50284,,3531866,CHEMBL1285074,Antimicrobial activity against Coprobacillus cateniformis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50285,,3531871,CHEMBL1285076,Antimicrobial activity against Eggerthella lenta by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,MIC90,ug ml-1,UO_0000274,1024.0
50286,,3531876,CHEMBL1285799,Antimicrobial activity against Eubacterium alactolyticum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50287,,3531881,CHEMBL1285801,Antimicrobial activity against Eubacterium biforme by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50288,,3531886,CHEMBL1285803,Antimicrobial activity against Eubacterium callanderi by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50289,,3531891,CHEMBL1285805,Antimicrobial activity against Eubacterium cylindroides by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50290,,3531896,CHEMBL1285807,Antimicrobial activity against Eubacterium limosum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL613084,Eubacterium limosum,Eubacterium limosum,1736.0,,MIC90,ug ml-1,UO_0000274,1024.0
50291,,3531901,CHEMBL1285809,Antimicrobial activity against Eubacterium rectale by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50292,,3531906,CHEMBL1285811,Antimicrobial activity against Eubacterium saburreum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50293,,3531911,CHEMBL1285813,Antimicrobial activity against Holdemania filiformis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50294,,3531916,CHEMBL1285815,Antimicrobial activity against Lactobacillus acidophilus by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL4296574,Lactobacillus acidophilus,Lactobacillus acidophilus,1579.0,,MIC90,ug ml-1,UO_0000274,1024.0
50295,,3531921,CHEMBL1285817,Antimicrobial activity against Lactobacillus catenaformis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50296,,3531926,CHEMBL1285819,Antimicrobial activity against Lactobacillus fermentum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL613076,Limosilactobacillus fermentum,Limosilactobacillus fermentum,1613.0,,MIC90,ug ml-1,UO_0000274,1024.0
50297,,3531931,CHEMBL1285821,Antimicrobial activity against Lactobacillus jensenii by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL4513201,Lactobacillus jensenii,Lactobacillus jensenii,109790.0,,MIC90,ug ml-1,UO_0000274,1024.0
50298,,3531936,CHEMBL1285823,Antimicrobial activity against Lactobacillus plantarum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614973,Lactiplantibacillus plantarum,Lactiplantibacillus plantarum,1590.0,,MIC90,ug ml-1,UO_0000274,1024.0
50299,,3531941,CHEMBL1285825,Antimicrobial activity against Lactobacillus reuteri by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL4296576,Limosilactobacillus reuteri,Limosilactobacillus reuteri,1598.0,,MIC90,ug ml-1,UO_0000274,1024.0
50300,,3531946,CHEMBL1285827,Antimicrobial activity against Lactobacillus rhamnosus by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL2366698,Lacticaseibacillus rhamnosus,Lacticaseibacillus rhamnosus,47715.0,,MIC90,ug ml-1,UO_0000274,1024.0
50301,,3531951,CHEMBL1285829,Antimicrobial activity against Lactobacillus sp. by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL615088,Lactobacillus sp.,Lactobacillus sp.,1591.0,,MIC90,ug ml-1,UO_0000274,1024.0
50302,,3531956,CHEMBL1285831,Antimicrobial activity against Propionibacterium acnes by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,MIC90,ug ml-1,UO_0000274,1024.0
50303,,3531961,CHEMBL1285833,Antimicrobial activity against Propionibacterium avidum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50304,,3531966,CHEMBL1285835,Antimicrobial activity against Propionibacterium propionicum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50305,,3531971,CHEMBL1285837,Antimicrobial activity against Anaerococcus prevotii by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,MIC90,ug ml-1,UO_0000274,512.0
50306,,3531976,CHEMBL1285956,Antimicrobial activity against Anaerococcus tetradius by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,MIC90,ug ml-1,UO_0000274,512.0
50307,,3531981,CHEMBL1285958,Antimicrobial activity against Finegoldia magna by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC90,ug ml-1,UO_0000274,512.0
50308,,3531986,CHEMBL1285960,Antimicrobial activity against Peptoniphilus asaccharolyticus by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC90,ug ml-1,UO_0000274,512.0
50309,,3531991,CHEMBL1285962,Antimicrobial activity against Peptoniphilus harei by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50310,,3531996,CHEMBL1285964,Antimicrobial activity against Peptostreptococcus anaerobius by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC90,ug ml-1,UO_0000274,512.0
50311,,3532001,CHEMBL1285966,Antimicrobial activity against Peptostreptococcus micros by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC90,ug ml-1,UO_0000274,512.0
50312,,3532006,CHEMBL1285968,Antimicrobial activity against Ruminococcus flavefaciens by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50313,,3532011,CHEMBL1285970,Antimicrobial activity against Ruminococcus gnavus by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50314,,3532016,CHEMBL1285972,Antimicrobial activity against Ruminococcus lactaris by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50315,,3532021,CHEMBL1285974,Antimicrobial activity against Ruminococcus luti by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50316,,3532026,CHEMBL1285976,Antimicrobial activity against Ruminococcus obeum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50317,,3532031,CHEMBL1285978,Antimicrobial activity against Ruminococcus productus by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50318,,3532036,CHEMBL1285980,Antimicrobial activity against Ruminococcus torques by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50319,,3532041,CHEMBL1283956,Antimicrobial activity against Clostridium hathewayi by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,4.0
50320,,3532048,CHEMBL1283960,Antimicrobial activity against Clostridium orbiscindens by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,128.0
50321,,3532052,CHEMBL1283964,Antimicrobial activity against Clostridium acetobutylicum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614961,Clostridium acetobutylicum,Clostridium acetobutylicum,1488.0,,MIC,ug ml-1,UO_0000274,1.0
50322,,3532057,CHEMBL1283966,Antimicrobial activity against Clostridium aminobutyricum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50323,,3532062,CHEMBL1283968,Antimicrobial activity against Clostridium bartlettii by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50324,,3532067,CHEMBL1283970,Antimicrobial activity against Clostridium beijerinckii by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,MIC,ug ml-1,UO_0000274,1.0
50325,,3532072,CHEMBL1283972,Antimicrobial activity against Clostridium bifermentans by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,MIC,ug ml-1,UO_0000274,1.0
50326,,3532077,CHEMBL1283974,Antimicrobial activity against Clostridium bolteae by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50327,,3532082,CHEMBL1283976,Antimicrobial activity against Clostridium butyricum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,MIC,ug ml-1,UO_0000274,1.0
50328,,3532087,CHEMBL1283978,Antimicrobial activity against Clostridium cadaveris by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614970,Clostridium cadaveris,Clostridium cadaveris,1529.0,,MIC,ug ml-1,UO_0000274,1.0
50329,,3532092,CHEMBL1284138,Antimicrobial activity against Clostridium cocleatum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50330,,3533143,CHEMBL1284868,Antimicrobial activity against Clostridium disporicum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50331,,3533148,CHEMBL1284870,Antimicrobial activity against Clostridium fallax by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50332,,3533153,CHEMBL1284872,Antimicrobial activity against Clostridium glycolicum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50333,,3533158,CHEMBL1284874,Antimicrobial activity against Clostridium hastiforme by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50334,,3533163,CHEMBL1284876,Antimicrobial activity against Clostridium lactatifermentans by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50335,,3533168,CHEMBL1284878,Antimicrobial activity against Clostridium leptum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50336,,3533173,CHEMBL1284880,Antimicrobial activity against Clostridium nexile by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50337,,3533178,CHEMBL1284882,Antimicrobial activity against Clostridium paraputrificum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC,ug ml-1,UO_0000274,1.0
50338,,3533183,CHEMBL1284884,Antimicrobial activity against Clostridium ramosum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,MIC,ug ml-1,UO_0000274,1.0
50339,,3533188,CHEMBL1284886,Antimicrobial activity against Clostridium rectum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50340,,3533193,CHEMBL1284888,Antimicrobial activity against Clostridium scindens by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50341,,3533198,CHEMBL1284890,Antimicrobial activity against Clostridium septicum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,MIC,ug ml-1,UO_0000274,1.0
50342,,3533203,CHEMBL1284892,Antimicrobial activity against Clostridium sordellii by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,MIC,ug ml-1,UO_0000274,1.0
50343,,3533208,CHEMBL1284894,Antimicrobial activity against Clostridium sp. by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50344,,3533213,CHEMBL1284896,Antimicrobial activity against Clostridium spiroforme by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50345,,3533218,CHEMBL1284898,Antimicrobial activity against Clostridium sporogenes by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,MIC,ug ml-1,UO_0000274,1.0
50346,,3533223,CHEMBL1284900,Antimicrobial activity against Clostridium subterminale by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50347,,3533228,CHEMBL1285042,Antimicrobial activity against Clostridium symbiosum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
50348,,3533233,CHEMBL1285044,Antimicrobial activity against Clostridium tertium by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC,ug ml-1,UO_0000274,1.0
50349,,3533238,CHEMBL1285046,Antimicrobial activity against Actinomyces meyeri by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,MIC,ug ml-1,UO_0000274,2.0
50350,,3533243,CHEMBL1285048,Antimicrobial activity against Actinomyces odontolyticus by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50351,,3533248,CHEMBL1285050,Antimicrobial activity against Actinomyces viscosus by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,MIC,ug ml-1,UO_0000274,2.0
50352,,3533253,CHEMBL1285052,Antimicrobial activity against Atopobium minutum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50353,,3533258,CHEMBL1285054,Antimicrobial activity against Bifidobacterium adolescentis by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50354,,3533263,CHEMBL1285056,Antimicrobial activity against Bifidobacterium bifidum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC,ug ml-1,UO_0000274,2.0
50355,,3533268,CHEMBL1285058,Antimicrobial activity against Bifidobacterium breve by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC,ug ml-1,UO_0000274,2.0
50356,,3533273,CHEMBL1285060,Antimicrobial activity against Bifidobacterium dentium by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50357,,3533278,CHEMBL1285062,Antimicrobial activity against Bifidobacterium infantis by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50358,,3533283,CHEMBL1285064,Antimicrobial activity against Bifidobacterium longum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC,ug ml-1,UO_0000274,2.0
50359,,3533288,CHEMBL1285066,Antimicrobial activity against Bifidobacterium pseudocatenulatum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50360,,3533293,CHEMBL1285068,Antimicrobial activity against Bifidobacterium pseudolongum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50361,,3533298,CHEMBL1285070,Antimicrobial activity against Catenibacterium mitsuokai by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50362,,3533303,CHEMBL1285072,Antimicrobial activity against Colinsella aerofaciens by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,MIC,ug ml-1,UO_0000274,2.0
50363,,3533308,CHEMBL1285074,Antimicrobial activity against Coprobacillus cateniformis by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50364,,3533313,CHEMBL1285076,Antimicrobial activity against Eggerthella lenta by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,MIC,ug ml-1,UO_0000274,2.0
50365,,3533318,CHEMBL1285799,Antimicrobial activity against Eubacterium alactolyticum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50366,,3533323,CHEMBL1285801,Antimicrobial activity against Eubacterium biforme by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50367,,3533328,CHEMBL1285803,Antimicrobial activity against Eubacterium callanderi by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50368,,3533333,CHEMBL1285805,Antimicrobial activity against Eubacterium cylindroides by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50369,,3533338,CHEMBL1285807,Antimicrobial activity against Eubacterium limosum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613084,Eubacterium limosum,Eubacterium limosum,1736.0,,MIC,ug ml-1,UO_0000274,2.0
50370,,3533343,CHEMBL1285809,Antimicrobial activity against Eubacterium rectale by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50371,,3533348,CHEMBL1285811,Antimicrobial activity against Eubacterium saburreum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50372,,3533353,CHEMBL1285813,Antimicrobial activity against Holdemania filiformis by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50373,,3533358,CHEMBL1285815,Antimicrobial activity against Lactobacillus acidophilus by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL4296574,Lactobacillus acidophilus,Lactobacillus acidophilus,1579.0,,MIC,ug ml-1,UO_0000274,2.0
50374,,3533363,CHEMBL1285817,Antimicrobial activity against Lactobacillus catenaformis by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50375,,3533368,CHEMBL1285819,Antimicrobial activity against Lactobacillus fermentum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613076,Limosilactobacillus fermentum,Limosilactobacillus fermentum,1613.0,,MIC,ug ml-1,UO_0000274,2.0
50376,,3533373,CHEMBL1285821,Antimicrobial activity against Lactobacillus jensenii by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL4513201,Lactobacillus jensenii,Lactobacillus jensenii,109790.0,,MIC,ug ml-1,UO_0000274,2.0
50377,,3533378,CHEMBL1285823,Antimicrobial activity against Lactobacillus plantarum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614973,Lactiplantibacillus plantarum,Lactiplantibacillus plantarum,1590.0,,MIC,ug ml-1,UO_0000274,2.0
50378,,3533383,CHEMBL1285825,Antimicrobial activity against Lactobacillus reuteri by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL4296576,Limosilactobacillus reuteri,Limosilactobacillus reuteri,1598.0,,MIC,ug ml-1,UO_0000274,2.0
50379,,3533388,CHEMBL1285827,Antimicrobial activity against Lactobacillus rhamnosus by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL2366698,Lacticaseibacillus rhamnosus,Lacticaseibacillus rhamnosus,47715.0,,MIC,ug ml-1,UO_0000274,2.0
50380,,3533393,CHEMBL1285829,Antimicrobial activity against Lactobacillus sp. by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL615088,Lactobacillus sp.,Lactobacillus sp.,1591.0,,MIC,ug ml-1,UO_0000274,2.0
50381,,3533398,CHEMBL1285831,Antimicrobial activity against Propionibacterium acnes by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,MIC,ug ml-1,UO_0000274,2.0
50382,,3533403,CHEMBL1285833,Antimicrobial activity against Propionibacterium avidum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50383,,3533408,CHEMBL1285835,Antimicrobial activity against Propionibacterium propionicum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50384,,3533413,CHEMBL1285837,Antimicrobial activity against Anaerococcus prevotii by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,MIC,ug ml-1,UO_0000274,2.0
50385,,3533418,CHEMBL1285956,Antimicrobial activity against Anaerococcus tetradius by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,MIC,ug ml-1,UO_0000274,2.0
50386,,3533423,CHEMBL1285958,Antimicrobial activity against Finegoldia magna by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC,ug ml-1,UO_0000274,2.0
50387,,3533428,CHEMBL1285960,Antimicrobial activity against Peptoniphilus asaccharolyticus by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC,ug ml-1,UO_0000274,2.0
50388,,3533433,CHEMBL1285962,Antimicrobial activity against Peptoniphilus harei by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50389,,3533438,CHEMBL1285964,Antimicrobial activity against Peptostreptococcus anaerobius by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC,ug ml-1,UO_0000274,2.0
50390,,3533443,CHEMBL1285966,Antimicrobial activity against Peptostreptococcus micros by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC,ug ml-1,UO_0000274,2.0
50391,,3533448,CHEMBL1285968,Antimicrobial activity against Ruminococcus flavefaciens by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50392,,3533453,CHEMBL1285970,Antimicrobial activity against Ruminococcus gnavus by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50393,,3533458,CHEMBL1285972,Antimicrobial activity against Ruminococcus lactaris by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50394,,3534526,CHEMBL1285974,Antimicrobial activity against Ruminococcus luti by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50395,,3534531,CHEMBL1285976,Antimicrobial activity against Ruminococcus obeum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50396,,3534536,CHEMBL1285978,Antimicrobial activity against Ruminococcus productus by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50397,,3534541,CHEMBL1285980,Antimicrobial activity against Ruminococcus torques by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
50398,,3548765,CHEMBL1282865,Antimicrobial activity against Bacteroides fragilis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC50,ug ml-1,UO_0000274,1024.0
50399,,3549860,CHEMBL1282864,Antimicrobial activity against Parabacteroides distasonis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,1024.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC50,ug ml-1,UO_0000274,1024.0
50400,,3549865,CHEMBL1282868,Antimicrobial activity against Parabacteroides merdae by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,1024.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,MIC50,ug ml-1,UO_0000274,1024.0
50401,,3549870,CHEMBL1282870,Antimicrobial activity against Parabacteroides goldsteinii by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,1024.0
50402,,3549875,CHEMBL1282872,Antimicrobial activity against Bacteroides ovatus by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC50,ug ml-1,UO_0000274,1024.0
50403,,3549880,CHEMBL1282874,Antimicrobial activity against Bacteroides thetaiotaomicron by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC50,ug ml-1,UO_0000274,1024.0
50404,,3549885,CHEMBL1282865,Antimicrobial activity against Bacteroides fragilis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,ug ml-1,UO_0000274,1024.0
50405,,3549892,CHEMBL1282864,Antimicrobial activity against Parabacteroides distasonis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC90,ug ml-1,UO_0000274,1024.0
50406,,3549896,CHEMBL1282864,Antimicrobial activity against Parabacteroides distasonis by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC,ug ml-1,UO_0000274,512.0
50407,,3549900,CHEMBL1282868,Antimicrobial activity against Parabacteroides merdae by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,MIC90,ug ml-1,UO_0000274,1024.0
50408,,3549904,CHEMBL1282868,Antimicrobial activity against Parabacteroides merdae by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,MIC,ug ml-1,UO_0000274,512.0
50409,,3549914,CHEMBL1282870,Antimicrobial activity against Parabacteroides goldsteinii by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50410,,3549918,CHEMBL1282870,Antimicrobial activity against Parabacteroides goldsteinii by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,512.0
50411,,3549922,CHEMBL1282872,Antimicrobial activity against Bacteroides ovatus by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC90,ug ml-1,UO_0000274,1024.0
50412,,3549931,CHEMBL1282874,Antimicrobial activity against Bacteroides thetaiotaomicron by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC90,ug ml-1,UO_0000274,1024.0
50413,,3549940,CHEMBL1283019,Antimicrobial activity against Bacteroides caccae by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC50,ug ml-1,UO_0000274,1024.0
50414,,3549945,CHEMBL1283021,Antimicrobial activity against Bacteroides nordii by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,1024.0
50415,,3549950,CHEMBL1283023,Antimicrobial activity against Bacteroides stercoris by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,MIC50,ug ml-1,UO_0000274,1024.0
50416,,3549955,CHEMBL1283025,Antimicrobial activity against Bacteroides uniformis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC50,ug ml-1,UO_0000274,1024.0
50417,,3549960,CHEMBL1283027,Antimicrobial activity against Bilophila wadsworthia by Wadsworth agar dilution method in presence of 1% pyruvic acid,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,1024.0
50418,,3549965,CHEMBL1283764,Antimicrobial activity against Desulfovibrio desulfuricans by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,1024.0
50419,,3549974,CHEMBL1283019,Antimicrobial activity against Bacteroides caccae by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC90,ug ml-1,UO_0000274,1024.0
50420,,3549983,CHEMBL1283021,Antimicrobial activity against Bacteroides nordii by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50421,,3549988,CHEMBL1283023,Antimicrobial activity against Bacteroides stercoris by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,MIC90,ug ml-1,UO_0000274,1024.0
50422,,3549993,CHEMBL1283025,Antimicrobial activity against Bacteroides uniformis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC90,ug ml-1,UO_0000274,1024.0
50423,,3549998,CHEMBL1283027,Antimicrobial activity against Bilophila wadsworthia by Wadsworth agar dilution method in presence of 1% pyruvic acid,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50424,,3550034,CHEMBL1283764,Antimicrobial activity against Desulfovibrio desulfuricans by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50425,,3550035,CHEMBL1283764,Antimicrobial activity against Desulfovibrio desulfuricans by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1024.0
50426,,3550036,CHEMBL1283766,Antimicrobial activity against Desulfovibrio fairfieldensis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50427,,3550040,CHEMBL1283768,Antimicrobial activity against Desulfovibrio piger by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50428,,3550044,CHEMBL1283770,Antimicrobial activity against Desulfovibrio vulgaris by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50429,,3550048,CHEMBL1283772,Antimicrobial activity against Desulfovibrio sp. by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50430,,3550052,CHEMBL1283774,Antimicrobial activity against Fusobacterium nucleatum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,1024.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC50,ug ml-1,UO_0000274,1024.0
50431,,3550058,CHEMBL1283777,Antimicrobial activity against Fusobacterium mortiferum by Wadsworth agar dilution method in presence of beta-lactamase inhibitor Sulbactam,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC50,ug ml-1,UO_0000274,512.0
50432,,3550062,CHEMBL1283778,Antimicrobial activity against Fusobacterium necrophorum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,MIC50,ug ml-1,UO_0000274,512.0
50433,,3550067,CHEMBL1283780,Antimicrobial activity against Fusobacterium varium by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC50,ug ml-1,UO_0000274,512.0
50434,,3550072,CHEMBL1283930,Antimicrobial activity against Fusobacterium sp. by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,MIC50,ug ml-1,UO_0000274,512.0
50435,,3550077,CHEMBL1283932,Antimicrobial activity against Porphyromonas sp. by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,512.0
50436,,3550082,CHEMBL1283934,Antimicrobial activity against Porphyromonas asaccharolyticus by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL615058,Porphyromonas asaccharolytica,Porphyromonas asaccharolytica,28123.0,,MIC50,ug ml-1,UO_0000274,512.0
50437,,3550087,CHEMBL1283936,Antimicrobial activity against Porphyromonas somerae by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL615060,Porphyromonas somerae,Porphyromonas somerae,322095.0,,MIC50,ug ml-1,UO_0000274,512.0
50438,,3550092,CHEMBL1283938,Antimicrobial activity against Porphyromonas uenonis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,512.0
50439,,3550097,CHEMBL1283940,Antimicrobial activity against Prevotella bivia by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC50,ug ml-1,UO_0000274,512.0
50440,,3550102,CHEMBL1283942,Antimicrobial activity against Prevotella corporis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,MIC50,ug ml-1,UO_0000274,512.0
50441,,3550107,CHEMBL1283944,Antimicrobial activity against Prevotella disiens by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,MIC50,ug ml-1,UO_0000274,512.0
50442,,3550112,CHEMBL1283946,Antimicrobial activity against Prevotella intermedia by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC50,ug ml-1,UO_0000274,512.0
50443,,3550117,CHEMBL1283948,Antimicrobial activity against Prevotella loescheii by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,MIC50,ug ml-1,UO_0000274,512.0
50444,,3550122,CHEMBL1283950,Antimicrobial activity against Prevotella melaninogenica by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,512.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC50,ug ml-1,UO_0000274,512.0
50445,,3550127,CHEMBL1283952,Antimicrobial activity against Clostridium clostridioforme by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,MIC50,ug ml-1,UO_0000274,128.0
50446,,3550132,CHEMBL1283954,Antimicrobial activity against Clostridium difficile by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC50,ug ml-1,UO_0000274,256.0
50447,,3550137,CHEMBL1283766,Antimicrobial activity against Desulfovibrio fairfieldensis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50448,,3550141,CHEMBL1283768,Antimicrobial activity against Desulfovibrio piger by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50449,,3550145,CHEMBL1283770,Antimicrobial activity against Desulfovibrio vulgaris by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50450,,3550149,CHEMBL1283772,Antimicrobial activity against Desulfovibrio sp. by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50451,,3550153,CHEMBL1283774,Antimicrobial activity against Fusobacterium nucleatum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC90,ug ml-1,UO_0000274,1024.0
50452,,3550159,CHEMBL1283777,Antimicrobial activity against Fusobacterium mortiferum by Wadsworth agar dilution method in presence of beta-lactamase inhibitor Sulbactam,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC90,ug ml-1,UO_0000274,1024.0
50453,,3550163,CHEMBL1283778,Antimicrobial activity against Fusobacterium necrophorum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,MIC90,ug ml-1,UO_0000274,1024.0
50454,,3550168,CHEMBL1283780,Antimicrobial activity against Fusobacterium varium by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC90,ug ml-1,UO_0000274,1024.0
50455,,3550173,CHEMBL1283930,Antimicrobial activity against Fusobacterium sp. by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,MIC90,ug ml-1,UO_0000274,1024.0
50456,,3550178,CHEMBL1283932,Antimicrobial activity against Porphyromonas sp. by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50457,,3550183,CHEMBL1283934,Antimicrobial activity against Porphyromonas asaccharolyticus by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL615058,Porphyromonas asaccharolytica,Porphyromonas asaccharolytica,28123.0,,MIC90,ug ml-1,UO_0000274,1024.0
50458,,3550188,CHEMBL1283936,Antimicrobial activity against Porphyromonas somerae by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL615060,Porphyromonas somerae,Porphyromonas somerae,322095.0,,MIC90,ug ml-1,UO_0000274,1024.0
50459,,3551267,CHEMBL1283938,Antimicrobial activity against Porphyromonas uenonis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50460,,3551272,CHEMBL1283940,Antimicrobial activity against Prevotella bivia by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC90,ug ml-1,UO_0000274,1024.0
50461,,3551277,CHEMBL1283942,Antimicrobial activity against Prevotella corporis by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,MIC90,ug ml-1,UO_0000274,1024.0
50462,,3551282,CHEMBL1283944,Antimicrobial activity against Prevotella disiens by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,MIC90,ug ml-1,UO_0000274,1024.0
50463,,3551287,CHEMBL1283946,Antimicrobial activity against Prevotella intermedia by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC90,ug ml-1,UO_0000274,1024.0
50464,,3551292,CHEMBL1283948,Antimicrobial activity against Prevotella loescheii by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,MIC90,ug ml-1,UO_0000274,1024.0
50465,,3551297,CHEMBL1283950,Antimicrobial activity against Prevotella melaninogenica by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC90,ug ml-1,UO_0000274,1024.0
50466,,3551302,CHEMBL1283952,Antimicrobial activity against Clostridium clostridioforme by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,MIC90,ug ml-1,UO_0000274,128.0
50467,,3551307,CHEMBL1283954,Antimicrobial activity against Clostridium difficile by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC90,ug ml-1,UO_0000274,512.0
50468,,3551312,CHEMBL1283766,Antimicrobial activity against Desulfovibrio fairfieldensis by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,32.0
50469,,3551316,CHEMBL1283768,Antimicrobial activity against Desulfovibrio piger by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,32.0
50470,,3551320,CHEMBL1283770,Antimicrobial activity against Desulfovibrio vulgaris by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,32.0
50471,,3551324,CHEMBL1283772,Antimicrobial activity against Desulfovibrio sp. by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,32.0
50472,,3551328,CHEMBL1283774,Antimicrobial activity against Fusobacterium nucleatum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC,ug ml-1,UO_0000274,128.0
50473,,3551333,CHEMBL1283777,Antimicrobial activity against Fusobacterium mortiferum by Wadsworth agar dilution method in presence of beta-lactamase inhibitor Sulbactam,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC,ug ml-1,UO_0000274,2.0
50474,,3551337,CHEMBL1283778,Antimicrobial activity against Fusobacterium necrophorum by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,MIC,ug ml-1,UO_0000274,2.0
50475,,3551342,CHEMBL1283780,Antimicrobial activity against Fusobacterium varium by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC,ug ml-1,UO_0000274,2.0
50476,,3551347,CHEMBL1283930,Antimicrobial activity against Fusobacterium sp. by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,MIC,ug ml-1,UO_0000274,2.0
50477,,3551352,CHEMBL1283932,Antimicrobial activity against Porphyromonas sp. by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,256.0
50478,,3551357,CHEMBL1283934,Antimicrobial activity against Porphyromonas asaccharolyticus by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL615058,Porphyromonas asaccharolytica,Porphyromonas asaccharolytica,28123.0,,MIC,ug ml-1,UO_0000274,256.0
50479,,3551362,CHEMBL1283936,Antimicrobial activity against Porphyromonas somerae by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL615060,Porphyromonas somerae,Porphyromonas somerae,322095.0,,MIC,ug ml-1,UO_0000274,256.0
50480,,3551367,CHEMBL1283938,Antimicrobial activity against Porphyromonas uenonis by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,256.0
50481,,3551372,CHEMBL1283940,Antimicrobial activity against Prevotella bivia by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC,ug ml-1,UO_0000274,8.0
50482,,3551377,CHEMBL1283942,Antimicrobial activity against Prevotella corporis by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,MIC,ug ml-1,UO_0000274,8.0
50483,,3551382,CHEMBL1283944,Antimicrobial activity against Prevotella disiens by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,MIC,ug ml-1,UO_0000274,8.0
50484,,3551387,CHEMBL1283946,Antimicrobial activity against Prevotella intermedia by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC,ug ml-1,UO_0000274,8.0
50485,,3551392,CHEMBL1283948,Antimicrobial activity against Prevotella loescheii by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,MIC,ug ml-1,UO_0000274,8.0
50486,,3551397,CHEMBL1283950,Antimicrobial activity against Prevotella melaninogenica by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC,ug ml-1,UO_0000274,8.0
50487,,3551402,CHEMBL1283952,Antimicrobial activity against Clostridium clostridioforme by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,MIC,ug ml-1,UO_0000274,32.0
50488,,3551405,CHEMBL1283954,Antimicrobial activity against Clostridium difficile by Wadsworth agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,128.0
50489,,3551409,CHEMBL1283956,Antimicrobial activity against Clostridium hathewayi by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,64.0
50490,,3551414,CHEMBL1283958,Antimicrobial activity against Clostridium innocuum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC50,ug.mL-1,1024.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,MIC50,ug ml-1,UO_0000274,1024.0
50491,,3551419,CHEMBL1283960,Antimicrobial activity against Clostridium orbiscindens by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50492,,3551424,CHEMBL1283962,Antimicrobial activity against Clostridium perfringens by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,1024.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC50,ug ml-1,UO_0000274,1024.0
50493,,3551429,CHEMBL1283964,Antimicrobial activity against Clostridium acetobutylicum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL614961,Clostridium acetobutylicum,Clostridium acetobutylicum,1488.0,,MIC50,ug ml-1,UO_0000274,256.0
50494,,3551434,CHEMBL1283966,Antimicrobial activity against Clostridium aminobutyricum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50495,,3551439,CHEMBL1283968,Antimicrobial activity against Clostridium bartlettii by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50496,,3551444,CHEMBL1283970,Antimicrobial activity against Clostridium beijerinckii by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,MIC50,ug ml-1,UO_0000274,256.0
50497,,3551449,CHEMBL1283972,Antimicrobial activity against Clostridium bifermentans by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,MIC50,ug ml-1,UO_0000274,256.0
50498,,3551454,CHEMBL1283974,Antimicrobial activity against Clostridium bolteae by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50499,,3551459,CHEMBL1283976,Antimicrobial activity against Clostridium butyricum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,MIC50,ug ml-1,UO_0000274,256.0
50500,,3551464,CHEMBL1283978,Antimicrobial activity against Clostridium cadaveris by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL614970,Clostridium cadaveris,Clostridium cadaveris,1529.0,,MIC50,ug ml-1,UO_0000274,256.0
50501,,3551469,CHEMBL1284138,Antimicrobial activity against Clostridium cocleatum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50502,,3551474,CHEMBL1284868,Antimicrobial activity against Clostridium disporicum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50503,,3551479,CHEMBL1284870,Antimicrobial activity against Clostridium fallax by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50504,,3551484,CHEMBL1284872,Antimicrobial activity against Clostridium glycolicum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50505,,3551489,CHEMBL1284874,Antimicrobial activity against Clostridium hastiforme by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50506,,3551494,CHEMBL1284876,Antimicrobial activity against Clostridium lactatifermentans by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50507,,3551499,CHEMBL1284878,Antimicrobial activity against Clostridium leptum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50508,,3551504,CHEMBL1284880,Antimicrobial activity against Clostridium nexile by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50509,,3551509,CHEMBL1284882,Antimicrobial activity against Clostridium paraputrificum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC50,ug ml-1,UO_0000274,256.0
50510,,3551514,CHEMBL1284884,Antimicrobial activity against Clostridium ramosum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,MIC50,ug ml-1,UO_0000274,256.0
50511,,3551519,CHEMBL1284886,Antimicrobial activity against Clostridium rectum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50512,,3551524,CHEMBL1284888,Antimicrobial activity against Clostridium scindens by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50513,,3551529,CHEMBL1284890,Antimicrobial activity against Clostridium septicum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,MIC50,ug ml-1,UO_0000274,256.0
50514,,3551534,CHEMBL1284892,Antimicrobial activity against Clostridium sordellii by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,MIC50,ug ml-1,UO_0000274,256.0
50515,,3551539,CHEMBL1284894,Antimicrobial activity against Clostridium sp. by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50516,,3551544,CHEMBL1284896,Antimicrobial activity against Clostridium spiroforme by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50517,,3551549,CHEMBL1284898,Antimicrobial activity against Clostridium sporogenes by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,MIC50,ug ml-1,UO_0000274,256.0
50518,,3551554,CHEMBL1284900,Antimicrobial activity against Clostridium subterminale by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50519,,3551559,CHEMBL1285042,Antimicrobial activity against Clostridium symbiosum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,256.0
50520,,3551564,CHEMBL1285044,Antimicrobial activity against Clostridium tertium by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,256.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC50,ug ml-1,UO_0000274,256.0
50521,,3551569,CHEMBL1285046,Antimicrobial activity against Actinomyces meyeri by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,MIC50,ug ml-1,UO_0000274,128.0
50522,,3551574,CHEMBL1285048,Antimicrobial activity against Actinomyces odontolyticus by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50523,,3551579,CHEMBL1285050,Antimicrobial activity against Actinomyces viscosus by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,MIC50,ug ml-1,UO_0000274,128.0
50524,,3551584,CHEMBL1285052,Antimicrobial activity against Atopobium minutum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50525,,3551589,CHEMBL1285054,Antimicrobial activity against Bifidobacterium adolescentis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50526,,3551594,CHEMBL1285056,Antimicrobial activity against Bifidobacterium bifidum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL4523075,Bifidobacterium bifidum,Bifidobacterium bifidum,1681.0,,MIC50,ug ml-1,UO_0000274,128.0
50527,,3552651,CHEMBL1285058,Antimicrobial activity against Bifidobacterium breve by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL5209644,Bifidobacterium breve,Bifidobacterium breve,1685.0,,MIC50,ug ml-1,UO_0000274,128.0
50528,,3552656,CHEMBL1285060,Antimicrobial activity against Bifidobacterium dentium by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50529,,3552661,CHEMBL1285062,Antimicrobial activity against Bifidobacterium infantis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50530,,3552666,CHEMBL1285064,Antimicrobial activity against Bifidobacterium longum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL613911,Bifidobacterium longum,Bifidobacterium longum,216816.0,,MIC50,ug ml-1,UO_0000274,128.0
50531,,3552671,CHEMBL1285066,Antimicrobial activity against Bifidobacterium pseudocatenulatum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50532,,3552676,CHEMBL1285068,Antimicrobial activity against Bifidobacterium pseudolongum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50533,,3552681,CHEMBL1285070,Antimicrobial activity against Catenibacterium mitsuokai by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50534,,3552686,CHEMBL1285072,Antimicrobial activity against Colinsella aerofaciens by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,MIC50,ug ml-1,UO_0000274,128.0
50535,,3552691,CHEMBL1285074,Antimicrobial activity against Coprobacillus cateniformis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50536,,3552696,CHEMBL1285076,Antimicrobial activity against Eggerthella lenta by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,MIC50,ug ml-1,UO_0000274,128.0
50537,,3552701,CHEMBL1285799,Antimicrobial activity against Eubacterium alactolyticum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50538,,3552706,CHEMBL1285801,Antimicrobial activity against Eubacterium biforme by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50539,,3552711,CHEMBL1285803,Antimicrobial activity against Eubacterium callanderi by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50540,,3552716,CHEMBL1285805,Antimicrobial activity against Eubacterium cylindroides by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50541,,3552721,CHEMBL1285807,Antimicrobial activity against Eubacterium limosum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL613084,Eubacterium limosum,Eubacterium limosum,1736.0,,MIC50,ug ml-1,UO_0000274,128.0
50542,,3552726,CHEMBL1285809,Antimicrobial activity against Eubacterium rectale by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50543,,3552731,CHEMBL1285811,Antimicrobial activity against Eubacterium saburreum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50544,,3552736,CHEMBL1285813,Antimicrobial activity against Holdemania filiformis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50545,,3552741,CHEMBL1285815,Antimicrobial activity against Lactobacillus acidophilus by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL4296574,Lactobacillus acidophilus,Lactobacillus acidophilus,1579.0,,MIC50,ug ml-1,UO_0000274,128.0
50546,,3552746,CHEMBL1285817,Antimicrobial activity against Lactobacillus catenaformis by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50547,,3552751,CHEMBL1285819,Antimicrobial activity against Lactobacillus fermentum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL613076,Limosilactobacillus fermentum,Limosilactobacillus fermentum,1613.0,,MIC50,ug ml-1,UO_0000274,128.0
50548,,3552756,CHEMBL1285821,Antimicrobial activity against Lactobacillus jensenii by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL4513201,Lactobacillus jensenii,Lactobacillus jensenii,109790.0,,MIC50,ug ml-1,UO_0000274,128.0
50549,,3552761,CHEMBL1285823,Antimicrobial activity against Lactobacillus plantarum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL614973,Lactiplantibacillus plantarum,Lactiplantibacillus plantarum,1590.0,,MIC50,ug ml-1,UO_0000274,128.0
50550,,3552766,CHEMBL1285825,Antimicrobial activity against Lactobacillus reuteri by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL4296576,Limosilactobacillus reuteri,Limosilactobacillus reuteri,1598.0,,MIC50,ug ml-1,UO_0000274,128.0
50551,,3552771,CHEMBL1285827,Antimicrobial activity against Lactobacillus rhamnosus by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL2366698,Lacticaseibacillus rhamnosus,Lacticaseibacillus rhamnosus,47715.0,,MIC50,ug ml-1,UO_0000274,128.0
50552,,3552776,CHEMBL1285829,Antimicrobial activity against Lactobacillus sp. by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL615088,Lactobacillus sp.,Lactobacillus sp.,1591.0,,MIC50,ug ml-1,UO_0000274,128.0
50553,,3552781,CHEMBL1285831,Antimicrobial activity against Propionibacterium acnes by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,MIC50,ug ml-1,UO_0000274,128.0
50554,,3552786,CHEMBL1285833,Antimicrobial activity against Propionibacterium avidum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50555,,3552791,CHEMBL1285835,Antimicrobial activity against Propionibacterium propionicum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50556,,3552796,CHEMBL1285837,Antimicrobial activity against Anaerococcus prevotii by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,MIC50,ug ml-1,UO_0000274,128.0
50557,,3552801,CHEMBL1285956,Antimicrobial activity against Anaerococcus tetradius by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,MIC50,ug ml-1,UO_0000274,128.0
50558,,3552806,CHEMBL1285958,Antimicrobial activity against Finegoldia magna by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC50,ug ml-1,UO_0000274,128.0
50559,,3552811,CHEMBL1285960,Antimicrobial activity against Peptoniphilus asaccharolyticus by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC50,ug ml-1,UO_0000274,128.0
50560,,3552816,CHEMBL1285962,Antimicrobial activity against Peptoniphilus harei by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50561,,3552821,CHEMBL1285964,Antimicrobial activity against Peptostreptococcus anaerobius by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC50,ug ml-1,UO_0000274,128.0
50562,,3552826,CHEMBL1285966,Antimicrobial activity against Peptostreptococcus micros by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC50,ug ml-1,UO_0000274,128.0
50563,,3552831,CHEMBL1285968,Antimicrobial activity against Ruminococcus flavefaciens by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50564,,3552836,CHEMBL1285970,Antimicrobial activity against Ruminococcus gnavus by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50565,,3552841,CHEMBL1285972,Antimicrobial activity against Ruminococcus lactaris by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50566,,3552846,CHEMBL1285974,Antimicrobial activity against Ruminococcus luti by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50567,,3552851,CHEMBL1285976,Antimicrobial activity against Ruminococcus obeum by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50568,,3552856,CHEMBL1285978,Antimicrobial activity against Ruminococcus productus by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50569,,3552861,CHEMBL1285980,Antimicrobial activity against Ruminococcus torques by Wadsworth agar dilution method,F,BAO_0003035,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,128.0
50570,,3552866,CHEMBL1283956,Antimicrobial activity against Clostridium hathewayi by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50571,,3552871,CHEMBL1283958,Antimicrobial activity against Clostridium innocuum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,MIC90,ug ml-1,UO_0000274,1024.0
50572,,3552876,CHEMBL1283960,Antimicrobial activity against Clostridium orbiscindens by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,512.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,512.0
50573,,3552881,CHEMBL1283962,Antimicrobial activity against Clostridium perfringens by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,>,1,1,>,MIC90,ug.mL-1,1024.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,ug ml-1,UO_0000274,1024.0
50574,,3552886,CHEMBL1283964,Antimicrobial activity against Clostridium acetobutylicum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614961,Clostridium acetobutylicum,Clostridium acetobutylicum,1488.0,,MIC90,ug ml-1,UO_0000274,1024.0
50575,,3552891,CHEMBL1283966,Antimicrobial activity against Clostridium aminobutyricum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50576,,3552896,CHEMBL1283968,Antimicrobial activity against Clostridium bartlettii by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50577,,3552901,CHEMBL1283970,Antimicrobial activity against Clostridium beijerinckii by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,MIC90,ug ml-1,UO_0000274,1024.0
50578,,3552906,CHEMBL1283972,Antimicrobial activity against Clostridium bifermentans by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,MIC90,ug ml-1,UO_0000274,1024.0
50579,,3552911,CHEMBL1283974,Antimicrobial activity against Clostridium bolteae by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50580,,3552916,CHEMBL1283976,Antimicrobial activity against Clostridium butyricum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,MIC90,ug ml-1,UO_0000274,1024.0
50581,,3552921,CHEMBL1283978,Antimicrobial activity against Clostridium cadaveris by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614970,Clostridium cadaveris,Clostridium cadaveris,1529.0,,MIC90,ug ml-1,UO_0000274,1024.0
50582,,3552926,CHEMBL1284138,Antimicrobial activity against Clostridium cocleatum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50583,,3552931,CHEMBL1284868,Antimicrobial activity against Clostridium disporicum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50584,,3552936,CHEMBL1284870,Antimicrobial activity against Clostridium fallax by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50585,,3552941,CHEMBL1284872,Antimicrobial activity against Clostridium glycolicum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50586,,3552946,CHEMBL1284874,Antimicrobial activity against Clostridium hastiforme by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50587,,3552951,CHEMBL1284876,Antimicrobial activity against Clostridium lactatifermentans by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50588,,3552956,CHEMBL1284878,Antimicrobial activity against Clostridium leptum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50589,,3552961,CHEMBL1284880,Antimicrobial activity against Clostridium nexile by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50590,,3552966,CHEMBL1284882,Antimicrobial activity against Clostridium paraputrificum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC90,ug ml-1,UO_0000274,1024.0
50591,,3552971,CHEMBL1284884,Antimicrobial activity against Clostridium ramosum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,MIC90,ug ml-1,UO_0000274,1024.0
50592,,3552976,CHEMBL1284886,Antimicrobial activity against Clostridium rectum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50593,,3552981,CHEMBL1284888,Antimicrobial activity against Clostridium scindens by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1024.0
50594,,3552986,CHEMBL1284890,Antimicrobial activity against Clostridium septicum by Wadsworth agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275577,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968431,=,1,1,=,MIC90,ug.mL-1,1024.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,MIC90,ug ml-1,UO_0000274,1024.0
50595,Active,3569336,CHEMBL1280545,Induction of apoptosis in pig LLC-PK1 cells at 0.064 mM after 24 hrs electoporated in presence of compound,F,BAO_0000375,BAO_0000219,cell-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275426,Antimicrob Agents Chemother,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,968590,,1,0,,Activity,,,CHEMBL614577,Sus scrofa,LLC-PK1,9823.0,,Activity,,,
50596,,3571500,CHEMBL1280544,Antibacterial activity against Staphylococcus aureus RN4220 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275477,Antimicrob Agents Chemother,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969350,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50597,,3571501,CHEMBL1281302,Antimicrobial activity against Staphylococcus aureus 286607-R1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275477,Antimicrob Agents Chemother,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969350,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
50598,,3571502,CHEMBL1281303,Antimicrobial activity against Staphylococcus aureus 286607-R1 harboring wild type gyrB by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275477,Antimicrob Agents Chemother,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969350,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50599,,3571503,CHEMBL1281304,Antimicrobial activity against Staphylococcus aureus RN4220 expressing gyrB D437N mutant gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1275477,Antimicrob Agents Chemother,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969350,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50600,,3600542,CHEMBL1291477,Antibacterial activity against Staphylococcus aureus ATCC 13709,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1287692,Bioorg Med Chem Lett,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974067,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50601,,3600549,CHEMBL1291476,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1287692,Bioorg Med Chem Lett,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974067,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,3.0
50602,,5085389,CHEMBL1634296,Antimicrobial activity against Streptomyces coelicolor 1147 after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315533,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,MIC,ug ml-1,UO_0000274,0.3
50603,,5085398,CHEMBL1634297,Antimicrobial activity against streptomycin-resistant Streptomyces coelicolor KO-178 harboring rpsL K88E mutant gene after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315533,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,MIC,ug ml-1,UO_0000274,0.8
50604,,5085407,CHEMBL1634298,Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor KO-347 harboring rpsl P91S mutant gene after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315533,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,MIC,ug ml-1,UO_0000274,0.5
50605,,5085416,CHEMBL1634299,Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor 92G harboring rpsL gene with inserted glycine at position 92 after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315533,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,MIC,ug ml-1,UO_0000274,0.5
50606,,5085425,CHEMBL1634300,Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor SP1 harboring rpsL A262G and C271T mutant gene after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315533,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,MIC,ug ml-1,UO_0000274,0.2
50607,,5085434,CHEMBL1634449,Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor SP2 harboring rpsL K88E mutant gene and inserted glycine at position 92 of the gene after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629651,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315533,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL613092,Streptomyces coelicolor,Streptomyces coelicolor,1902.0,,MIC,ug ml-1,UO_0000274,0.2
50608,,5092233,CHEMBL1636188,Antimicrobial activity against Aerococcus viridans isolate PGS22 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,F,BAO_0000181,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629633,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315308,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,ug ml-1,UO_0000274,8.0
50609,,5092242,CHEMBL1636358,Antimicrobial activity against Shigella flexneri isolate C506 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629633,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315308,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,Activity,ug ml-1,UO_0000274,8.0
50610,,5092266,CHEMBL1636197,Antimicrobial activity against Pseudomonas putida isolate C231 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629633,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315308,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL612501,Pseudomonas putida,Pseudomonas putida,303.0,,Activity,ug ml-1,UO_0000274,8.0
50611,,5092268,CHEMBL1636196,Antimicrobial activity against Arthrobacter arilaitensis isolate C361 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,F,BAO_0000181,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629633,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315308,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,ug ml-1,UO_0000274,8.0
50612,,5092369,CHEMBL1636203,Antimicrobial activity against Acinetobacter lwoffii isolate C15 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629633,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315308,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,Activity,ug ml-1,UO_0000274,8.0
50613,,5092396,CHEMBL1636327,Antimicrobial activity against Acinetobacter rhizosphaerae isolate C44 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,F,BAO_0000181,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629633,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315308,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,ug ml-1,UO_0000274,8.0
50614,,5092397,CHEMBL1636328,Antimicrobial activity against Acinetobacter lwoffii isolate C141 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629633,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315308,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,Activity,ug ml-1,UO_0000274,8.0
50615,,5092398,CHEMBL1636329,Antimicrobial activity against Bacillus psychrodurans isolate C328 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,F,BAO_0000181,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629633,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315308,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,ug ml-1,UO_0000274,8.0
50616,,5099155,CHEMBL1638697,Binding affinity to RNA by RNA fluorescence assay,B,BAO_0000188,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629423,Bioorg Med Chem Lett,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1314973,=,1,1,=,EC50,nM,7.0,CHEMBL345,,Nucleic Acid,,,EC50,uM,UO_0000065,0.007
50617,,5099164,CHEMBL1638698,Binding affinity to Escherichia coli ribosome assessed as inhibition of transcription-translational activity by luciferase assay,B,BAO_0000190,BAO_0000220,subcellular format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629423,Bioorg Med Chem Lett,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1314973,=,1,1,=,IC50,nM,32.0,CHEMBL2363135,Bacteria,Bacterial 70S ribosome,2.0,,IC50,uM,UO_0000065,0.032
50618,,5099173,CHEMBL1638699,Binding affinity to ribosome in reticulocyte lysate assessed as inhibition of transcription-translational activity by luciferase assay,B,BAO_0000190,BAO_0000220,subcellular format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1629423,Bioorg Med Chem Lett,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1314973,=,1,1,=,IC50,nM,252000.0,CHEMBL613299,,Ribosome,,,IC50,uM,UO_0000065,252.0
50619,,5138613,CHEMBL1647497,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 after 12 to 18 hrs by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1641534,Bioorg Med Chem,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1320165,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,125.0
50620,,5138630,CHEMBL1647496,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 12 to 18 hrs by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1641534,Bioorg Med Chem,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1320165,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
50621,Not Determined,5138647,CHEMBL1647490,Antibacterial activity against Mycobacterium smegmatis ATCC 14468 after 12 to 18 hrs by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1641534,Bioorg Med Chem,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1320165,,1,0,,MIC,,,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,,,
50622,,5138664,CHEMBL1647495,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 12 to 18 hrs by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1641534,Bioorg Med Chem,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1320165,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
50623,,5138681,CHEMBL1647494,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 12 to 18 hrs by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1641534,Bioorg Med Chem,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1320165,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,125.0
50624,,5138698,CHEMBL1647493,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 12 to 18 hrs by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1641534,Bioorg Med Chem,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1320165,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
50625,,5138715,CHEMBL1647492,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 12 to 18 hrs by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1641534,Bioorg Med Chem,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1320165,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50626,,5138732,CHEMBL1647491,Antibacterial activity against Escherichia coli ATCC 25922 after 12 to 18 hrs by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1641534,Bioorg Med Chem,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1320165,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50627,,5146504,CHEMBL1666003,Antimicrobial activity against Pseudomonas aeruginosa isolate IMCJ798 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326505,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
50628,,5146505,CHEMBL1666004,Antimicrobial activity against Pseudomonas aeruginosa isolate IMCJ799 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326505,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
50629,,5146506,CHEMBL1666011,Antimicrobial activity against Escherichia coli JM109 transformant harboring pSTV28 plasmid by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326505,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
50630,,5146507,CHEMBL1666012,Antimicrobial activity against Escherichia coli JM109 transformant harboring pSTV28 plasmid expressing aac(6')-Iaf wild type gene by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326505,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50631,,5146508,CHEMBL1666013,Antimicrobial activity against Escherichia coli JM109 transformant harboring pSTV28 plasmid expressing aac(6')-Iaf (TTG-ATG) mutant gene by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326505,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50632,,5165983,CHEMBL1663827,Inhibition of rat phospholipase C,B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649335,Bioorg Med Chem,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1324149,=,1,1,=,IC50,nM,7.9,CHEMBL612545,,Unchecked,,,IC50,nM,UO_0000065,7.9
50633,,5169998,CHEMBL1659864,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolates by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323255,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,2.0
50634,,5170008,CHEMBL1659864,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolates by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323255,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,32.0
50635,,5170018,CHEMBL1659865,Antimicrobial activity against beta lactamase KPC-producing Klebsiella pneumoniae isolates by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323255,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,2.0
50636,,5171069,CHEMBL1659865,Antimicrobial activity against beta lactamase KPC-producing Klebsiella pneumoniae isolates by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323255,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,32.0
50637,,5181213,CHEMBL1667245,Antibacterial activity against Staphylococcus aureus RN4220 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327083,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50638,,5181214,CHEMBL1667246,"Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD, tet(L), dfrK and vga(C) gene by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327083,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
50639,,5181215,CHEMBL1667247,"Antibacterial activity against Staphylococcus aureus RN4220 harboring tet(L), dfrK gene by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327083,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50640,,5181216,CHEMBL1667248,Antibacterial activity against Staphylococcus aureus RN4220 harboring aadD and tet(L) gene by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1649544,Antimicrob Agents Chemother,2009.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327083,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
50641,Active,5294809,CHEMBL1696382,Inhibition of HIV1 Rev-radiolabeled Rev response element interaction after 10 mins by electrophoretic mobility shift assay,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1687710,Antimicrob Agents Chemother,2008.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,1337250,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
50642,,5296412,CHEMBL1691269,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ST398 isolate 11 containing apmA, erm(B), tet(L), tet(M), tet(K), dfrK, aadD, mecA, blaZ resistance genes by CLSI M31-A3 method",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1687809,Antimicrob Agents Chemother,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338225,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
50643,,5296413,CHEMBL1691270,Antimicrobial activity against Staphylococcus aureus RN4220 by CLSI M31-A3 method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1687809,Antimicrob Agents Chemother,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338225,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50644,,5296414,CHEMBL1691271,"Antimicrobial activity against Staphylococcus aureus RN4220 carrying pAFS11-apmA, erm(B), tet(L), dfrK, aadD resistance genes by CLSI M31-A3 method",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1687809,Antimicrob Agents Chemother,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338225,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
50645,no drug-induced liver injury reported,5317628,CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,BAO_0000179,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1341414,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
50646,drug-induced liver injury reported,5318579,CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,BAO_0000179,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1341414,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
50647,no drug-induced liver injury reported,5319530,CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,BAO_0000179,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1341414,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
50648,,6295181,CHEMBL1810772,Binding affinity to 2-AP labeled RNA1 by fluorescence binding assay,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1806453,Bioorg Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1445742,=,1,1,=,Kd,nM,1500.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,1.5
50649,,6295182,CHEMBL1810770,Binding affinity to 2-AP labeled mutant RNA3 by fluorescence binding assay,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1806453,Bioorg Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1445742,=,1,1,=,Kd,nM,1100.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,1.1
50650,,6295183,CHEMBL1810768,Binding affinity to 2-AP labeled mutant RNA5 by fluorescence binding assay,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1806453,Bioorg Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1445742,=,1,1,=,Kd,nM,1100.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,1.1
50651,,6295184,CHEMBL1810774,Binding affinity to 2-AP labeled mutant RNA7 by fluorescence binding assay,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1806453,Bioorg Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1445742,=,1,1,=,Kd,nM,1100.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,1.1
50652,,6329773,CHEMBL1820330,Inhibition of HIV1 TAR RNA,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1817564,Bioorg Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1450667,<,1,1,<,Kd,nM,1000.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,1.0
50653,,6329774,CHEMBL1820330,Inhibition of HIV1 TAR RNA,B,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1817564,Bioorg Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1450667,=,1,1,=,IC50,nM,417.0,CHEMBL345,,Nucleic Acid,,,IC50,nM,UO_0000065,417.0
50654,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714058,CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50655,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714059,CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50656,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714060,CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,IC50,,,
50657,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714061,CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,Ki,,,
50658,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714068,CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50659,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714069,CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50660,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714070,CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50661,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714071,CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50662,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714076,CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,IC50,,,
50663,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714077,CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,Ki,,,
50664,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714080,CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50665,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714081,CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50666,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7743978,CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50667,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7743979,CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50668,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7743980,CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,IC50,,,
50669,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7743981,CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,Ki,,,
50670,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7743982,CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,IC50,,,
50671,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7743983,CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,Ki,,,
50672,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744000,CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,IC50,,,
50673,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744001,CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,Ki,,,
50674,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744004,CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50675,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744005,CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50676,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744006,CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50677,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744007,CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50678,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744008,CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50679,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744009,CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,BAO_0000192,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50680,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744014,CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50681,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744015,CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50682,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744016,CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50683,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744017,CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50684,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744018,CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50685,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744019,CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50686,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746100,CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50687,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746101,CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50688,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746102,CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50689,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746103,CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50690,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746104,CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50691,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746105,CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50692,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746108,CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50693,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746109,CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50694,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746110,CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50695,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746111,CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50696,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746112,CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50697,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746113,CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50698,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746114,CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50699,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746115,CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50700,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746116,CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,IC50,,,
50701,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746117,CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,Ki,,,
50702,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746124,CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50703,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746125,CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50704,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746126,CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,IC50,,,
50705,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746127,CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,Ki,,,
50706,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746128,CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50707,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746129,CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50708,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746130,CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50709,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746131,CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50710,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746132,CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,IC50,,,
50711,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746133,CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,Ki,,,
50712,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746136,CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,IC50,,,
50713,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746137,CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,Ki,,,
50714,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746160,CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50715,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746161,CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50716,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746162,CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,IC50,,,
50717,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746163,CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,Ki,,,
50718,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746172,CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50719,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746173,CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50720,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746174,CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50721,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746175,CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50722,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746176,CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000190,BAO_0000219,cell-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50723,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746177,CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000192,BAO_0000219,cell-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50724,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746182,CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,BAO_0000190,BAO_0000219,cell-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50725,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746183,CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,BAO_0000192,BAO_0000219,cell-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50726,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746184,CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50727,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746185,CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50728,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746188,CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,IC50,,,
50729,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746189,CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,Ki,,,
50730,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746190,CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,IC50,,,
50731,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746191,CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,Ki,,,
50732,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746222,CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
50733,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746223,CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
50734,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746224,CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,IC50,,,
50735,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746225,CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,Ki,,,
50736,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746226,CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,IC50,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,IC50,,,
50737,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746227,CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1909046,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1539980,,15,0,,Ki,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,Ki,,,
50738,,8031346,CHEMBL1954715,Displacement of ethidium bromide from human pre-hsa-mir-155 miRNA after 30 mins,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1949550,Bioorg Med Chem Lett,2012.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1577846,=,1,1,=,Kd,nM,6000.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,6.0
50739,Dose-dependent effect,8031369,CHEMBL1954709,Binding affinity to human pre-hsa-mir-155 miRNA assessed as increase in melting temperature,B,BAO_0000375,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1949550,Bioorg Med Chem Lett,2012.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1577846,,1,0,,Activity,,,CHEMBL345,,Nucleic Acid,,,Activity,,,
50740,,8031371,CHEMBL1954708,Binding affinity to human pre-hsa-mir-155 miRNA assessed as inhibition of dicer-catalysed (33P)-labelled pre-miRNA processing at 1 mM after 1 hr by PAGE analysis,B,BAO_0000201,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1949550,Bioorg Med Chem Lett,2012.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,1577846,=,1,1,=,Inhibition,%,10.0,CHEMBL345,,Nucleic Acid,,,INH,%,UO_0000187,10.0
50741,,8031383,CHEMBL1954715,Displacement of ethidium bromide from human pre-hsa-mir-155 miRNA after 30 mins,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1949550,Bioorg Med Chem Lett,2012.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1577876,=,1,1,=,Kd,nM,11000.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,11.0
50742,,8031386,CHEMBL1954708,Binding affinity to human pre-hsa-mir-155 miRNA assessed as inhibition of dicer-catalysed (33P)-labelled pre-miRNA processing at 1 mM after 1 hr by PAGE analysis,B,BAO_0000201,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL1949550,Bioorg Med Chem Lett,2012.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,1577876,=,1,1,=,Inhibition,%,10.0,CHEMBL345,,Nucleic Acid,,,INH,%,UO_0000187,10.0
50743,,10900147,CHEMBL2039229,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2034941,ACS Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1645594,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
50744,,10900158,CHEMBL2039230,Antimicrobial activity against Staphylococcus aureus harboring APH(3'/5'''')-3 enzyme,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2034941,ACS Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1645594,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
50745,,10901049,CHEMBL2039231,Antimicrobial activity against Staphylococcus aureus harboring ANT(4')-1 enzyme,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2034941,ACS Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1645594,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
50746,,10901060,CHEMBL2039232,Antimicrobial activity against Staphylococcus aureus harboring APH(2'''') and AAC(6') enzymes,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2034941,ACS Med Chem Lett,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1645594,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
50747,,12476629,CHEMBL3057109,Antibacterial activity against Elizabethkingia meningoseptica ATCC 13253 after 16 to 18 hr by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3046423,Med Chem Res,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1808641,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL612601,Elizabethkingia meningoseptica,Elizabethkingia meningoseptica,238.0,,MIC,ug ml-1,UO_0000274,12.5
50748,,12476630,CHEMBL3057110,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 16 to 18 hr by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3046423,Med Chem Res,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1808641,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,6.25
50749,,12476631,CHEMBL3057111,Antibacterial activity against Klebsiella oxytoca ATCC 13182 after 16 to 18 hr by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3046423,Med Chem Res,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1808641,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,6.25
50750,,12476632,CHEMBL3057112,Antibacterial activity against Escherichia coli ATCC 35218 after 16 to 18 hr by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3046423,Med Chem Res,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1808641,=,1,1,=,MIC,ug.mL-1,3.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,3.13
50751,,12476633,CHEMBL3057113,Antibacterial activity against Staphylococcus aureus ATCC 43300 after 16 to 18 hr by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3046423,Med Chem Res,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1808641,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
50752,,12476634,CHEMBL3057114,Antibacterial activity against Staphylococcus xylosus ATCC 35033 after 16 to 18 hr by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3046423,Med Chem Res,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1808641,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,MIC,ug ml-1,UO_0000274,0.2
50753,,12476635,CHEMBL3057115,Antibacterial activity against Rhodococcus equi ATCC 6939 after 16 to 18 hr by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3046423,Med Chem Res,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1808641,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL612439,Prescottella equi,Prescottella equi,43767.0,,MIC,ug ml-1,UO_0000274,1.56
50754,,12476636,CHEMBL3057116,Antibacterial activity against Bacillus subtilis ATCC 6051 after 16 to 18 hr by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3046423,Med Chem Res,2011.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1808641,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.78
50755,,12586277,CHEMBL3070904,Antibacterial activity against Pseudomonas aeruginosa MTCC 2453 after 24 hr by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3045812,Med Chem Res,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838770,=,1,1,=,MIC,ug.mL-1,18.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,18.75
50756,,12586278,CHEMBL3070906,Antibacterial activity against Bacillus subtilis MTCC 121 after 24 hr by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3045812,Med Chem Res,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838770,=,1,1,=,MIC,ug.mL-1,18.75,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,18.75
50757,,12586279,CHEMBL3070905,Antibacterial activity against Staphylococcus aureus MLS16 MTCC 2940 after 24 hr by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3045812,Med Chem Res,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838770,=,1,1,=,MIC,ug.mL-1,18.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,18.75
50758,,12586280,CHEMBL3070907,Antibacterial activity against Staphylococcus aureus MTCC 96 after 24 hr by microtiter broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3045812,Med Chem Res,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838770,=,1,1,=,MIC,ug.mL-1,18.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,18.75
50759,Not Active,12705206,CHEMBL2345788,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as membrane disruption at 4 X MIC after 2 hrs by SYTOX staining-based fluorescence microscopic analysis,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2331416,Bioorg Med Chem Lett,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,1867424,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
50760,,12705218,CHEMBL2345790,Binding affinity to 2-AP labeled 16s rRNA (unknown origin) having pairing of C1405-G1496 by fluorescence assay,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2331416,Bioorg Med Chem Lett,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1867424,=,1,1,=,Kd,nM,1270.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,1.27
50761,,12705229,CHEMBL2345791,Binding affinity to 2-AP labeled 16s rRNA (unknown origin) having pairing of G1405-C1496 by fluorescence assay,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2331416,Bioorg Med Chem Lett,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1867424,=,1,1,=,Kd,nM,1148.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,1.148
50762,,12705240,CHEMBL2345792,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2331416,Bioorg Med Chem Lett,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1867424,=,1,1,=,MIC,nM,1100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.1
50763,,12705251,CHEMBL2345793,Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2331416,Bioorg Med Chem Lett,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1867424,=,1,1,=,MIC,nM,4400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,4.4
50764,,13461752,CHEMBL2434507,Antibacterial activity against Escherichia coli at 100 ug/ml after 24 hrs,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429819,Med Chem Res,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Millimeter,1920441,=,1,1,=,IZ,mm,26.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,26.12
50765,,13461753,CHEMBL2434508,Antibacterial activity against Bacillus subtilis at 100 ug/ml after 24 hrs,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429819,Med Chem Res,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Millimeter,1920441,=,1,1,=,IZ,mm,26.12,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,26.12
50766,,13461755,CHEMBL2434509,Antibacterial activity against Muscodor albus at 100 ug/ml after 24 hrs,F,BAO_0003039,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429819,Med Chem Res,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Millimeter,1920441,=,1,1,=,IZ,mm,25.78,CHEMBL3879801,,NON-PROTEIN TARGET,,,DIZ,mm,UO_0000016,25.78
50767,,13461756,CHEMBL2434506,Antibacterial activity against Proteus vulgaris at 100 ug/ml after 24 hrs,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429819,Med Chem Res,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Millimeter,1920441,=,1,1,=,IZ,mm,25.29,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,DIZ,mm,UO_0000016,25.29
50768,,13467027,CHEMBL2433960,Antibacterial activity against Escherichia coli L58058.1 expressing ANT2''-1A after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
50769,,13467052,CHEMBL2433961,Antibacterial activity against Escherichia coli PAZ505H8101 expressing AAC6'-1B after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50770,,13467725,CHEMBL2434815,Displacement of fluorescein and rhodamine-labeled TAT peptide from HIV TAR RNA by FRET assay,B,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429818,Bioorg Med Chem Lett,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,1921147,=,1,1,=,IC50,nM,1474.0,CHEMBL345,,Nucleic Acid,,,IC50,nM,UO_0000065,1474.0
50771,,13467970,CHEMBL2433962,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
50772,,13467995,CHEMBL2433963,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
50773,,13468021,CHEMBL2434109,Antibacterial activity against Pseudomonas aeruginosa PA22 (PT629) expressing MexXY after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
50774,,13468047,CHEMBL2434110,Antibacterial activity against Pseudomonas aeruginosa F03 expressing AAC6'-2A after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
50775,,13468073,CHEMBL2434111,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
50776,,13468099,CHEMBL2434112,Antibacterial activity against Acinetobacter lwoffii AI.88-483 expressing APH3'-6A after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,128.0
50777,,13468125,CHEMBL2434113,Antibacterial activity against Acinetobacter lwoffii ATCC 17925 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.5
50778,,13468154,CHEMBL2434114,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS2 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
50779,,13468183,CHEMBL2434115,Antibacterial activity against healthcare-acquired methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
50780,,13468212,CHEMBL2434116,Antibacterial activity against Staphylococcus aureus expressing aminoglycoside-4'-O-phosphoryltransferase after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
50781,,13468241,CHEMBL2434117,Antibacterial activity against Staphylococcus aureus expressing aminoglycoside-3'-O-phosphoryltransferase after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
50782,,13469163,CHEMBL2434118,Antibacterial activity against Staphylococcus aureus expressing aminoglycoside-6'-N-acetyltransferase/2''-O-phosphoryltransferase after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50783,,13469192,CHEMBL2434119,Antibacterial activity against 14- and 15-membered macrolide-resistant Staphylococcus aureus expressing MsrA efflux pump after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50784,,13469221,CHEMBL2434121,Antibacterial activity against fluoroquinolone-resistant Staphylococcus aureus 1199B expressing NorA efflux pump after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50785,,13469250,CHEMBL2434120,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922692,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
50786,,13880181,CHEMBL3108622,Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by microdilution broth method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3102810,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Micromolar,1960914,=,1,0,=,MIC95,uM,15.62,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC95,uM,UO_0000064,15.62
50787,,13880185,CHEMBL3106062,Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by microdilution broth method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3102810,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Micromolar,1960914,=,1,0,=,MIC95,uM,7.81,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC95,uM,UO_0000064,7.81
50788,,14657942,CHEMBL3266202,Inhibition of N-terminal FITC-labeled MBM1 interaction to menin (unknown origin) after 1 hr by fluorescence polarization assay,B,BAO_0000192,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3259787,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2099530,=,1,1,=,Ki,nM,18800.0,CHEMBL612545,,Unchecked,,,Ki,uM,UO_0000065,18.8
50789,,15119821,CHEMBL3387220,Antibacterial activity against Staphylococcus aureus MTCC 96 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3352042,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2270573,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.5
50790,,15119834,CHEMBL3387221,Antibacterial activity against Bacillus subtilis MTCC 121 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3352042,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2270573,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,12.5
50791,,15119847,CHEMBL3387222,Antibacterial activity against Staphylococcus aureus MLS16 MTCC 2940 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3352042,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2270573,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.5
50792,,15124278,CHEMBL3387223,Antibacterial activity against Micrococcus luteus MTC 2470 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3352042,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2270573,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,12.5
50793,,15124291,CHEMBL3387224,Antibacterial activity against Klebsiella planticola MTCC 530 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3352042,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2270573,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,ug ml-1,UO_0000274,12.5
50794,,15124304,CHEMBL3387225,Antibacterial activity against Escherichia coli MTCC 739 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3352042,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2270573,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,12.5
50795,,15124317,CHEMBL3387226,Antibacterial activity against Pseudomonas aeruginosa MTCC 2453 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3352042,Bioorg Med Chem Lett,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2270573,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,12.5
50796,,15638947,CHEMBL3591115,Antimicrobial activity against Fusarium graminearum B4-5A using RPMI medium by microbroth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588813,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486562,=,1,1,=,MIC,ug.mL-1,62.5,CHEMBL2366834,Fusarium graminearum,Fusarium graminearum,5518.0,,MIC,ug ml-1,UO_0000274,62.5
50797,,15638960,CHEMBL3591114,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated at 35 degC for 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588813,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486562,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
50798,,15638972,CHEMBL3591113,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 1299 assessed as inhibition of bacterial growth incubated at 35 degC for 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588813,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486562,>=,1,1,>=,MIC,ug.mL-1,250.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,250.0
50799,,15638984,CHEMBL3591112,Antimicrobial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated at 35 degC for 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588813,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486562,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50800,,15638996,CHEMBL3591111,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of bacterial growth incubated at 35 degC for 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588813,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486562,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,125.0
50801,,15639008,CHEMBL3591110,Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth incubated at 35 degC for 12 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588813,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486562,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50802,Not Determined,15640649,CHEMBL3592557,Binding affinity to HIV1 TAR RNA U3 bulge mutant at pH 6.8 by ethidium bromide displacement assay,B,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588850,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2486571,,1,0,,IC50,,,CHEMBL345,,Nucleic Acid,,,IC50,,,
50803,,15640659,CHEMBL3592556,Binding affinity to HIV1 TAR RNA bulgeless tetraloop mutant at pH 6.8 by ethidium bromide displacement assay,B,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588850,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2486571,=,1,1,=,IC50,nM,192000.0,CHEMBL345,,Nucleic Acid,,,IC50,uM,UO_0000065,192.0
50804,,15640669,CHEMBL3592555,Binding affinity to HIV1 TAR RNA tetraloop mutant at pH 6.8 by ethidium bromide displacement assay,B,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588850,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2486571,=,1,1,=,IC50,nM,684000.0,CHEMBL345,,Nucleic Acid,,,IC50,uM,UO_0000065,684.0
50805,,15640679,CHEMBL3592554,Binding affinity to HIV1 TAR RNA bulgeless mutant at pH 6.8 by ethidium bromide displacement assay,B,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588850,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2486571,=,1,1,=,IC50,nM,150000.0,CHEMBL345,,Nucleic Acid,,,IC50,uM,UO_0000065,150.0
50806,,15640689,CHEMBL3592553,Binding affinity to wild type HIV1 TAR RNA at pH 6.8 by ethidium bromide displacement assay,B,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3588850,Medchemcomm,2014.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2486571,=,1,1,=,IC50,nM,378000.0,CHEMBL345,,Nucleic Acid,,,IC50,uM,UO_0000065,378.0
50807,,15682717,CHEMBL3607623,"Inhibition of pre-miR-17 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer",B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,=,1,1,=,Inhibition,%,60.0,CHEMBL612545,,Unchecked,,,INH,%,UO_0000187,60.0
50808,,15683328,CHEMBL3607622,"Inhibition of pre-miR-373 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer",B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,=,1,1,=,Inhibition,%,60.0,CHEMBL612545,,Unchecked,,,INH,%,UO_0000187,60.0
50809,,15683339,CHEMBL3607621,"Inhibition of pre-miR-372 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer",B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,=,1,1,=,Inhibition,%,60.0,CHEMBL612545,,Unchecked,,,INH,%,UO_0000187,60.0
50810,,15683348,CHEMBL3607624,"Inhibition of pre-miR-21 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer",B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,=,1,1,=,Inhibition,%,60.0,CHEMBL612545,,Unchecked,,,INH,%,UO_0000187,60.0
50811,,15683359,CHEMBL3607625,"Inhibition of pre-miR-372 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer",B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2494670,=,1,1,=,IC50,nM,88200.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,88.2
50812,,15683377,CHEMBL3607729,"Inhibition of pre-miR-17 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer",B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2494670,=,1,1,=,IC50,nM,93700.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,93.7
50813,,15683395,CHEMBL3607730,"Inhibition of pre-miR-373 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer",B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2494670,=,1,1,=,IC50,nM,143000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,143.0
50814,,15683413,CHEMBL3607731,"Inhibition of pre-miR-21 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer",B,BAO_0000190,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2494670,=,1,1,=,IC50,nM,76700.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,76.7
50815,,15683431,CHEMBL3607732,Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) after 4 hrs by fluorescence assay,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2494670,=,1,1,=,Kd,nM,11600.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,11.6
50816,,15683449,CHEMBL3607733,Binding affinity to 5'-FAM-pre-miR-17 (unknown origin) after 4 hrs by fluorescence assay,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2494670,=,1,1,=,Kd,nM,1880.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,1.88
50817,,15683467,CHEMBL3607734,Binding affinity to 5'-FAM-pre-miR-373 (unknown origin) after 4 hrs by fluorescence assay,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2494670,=,1,1,=,Kd,nM,15200.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,15.2
50818,,15683485,CHEMBL3607735,Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) after 4 hrs by fluorescence assay in presence of 100-fold excess of Escherichia coli tRNA,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2494670,=,1,1,=,Kd,nM,11700.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,11.7
50819,,15683496,CHEMBL3607736,Ratio of Kd for 5'-FAM-pre-miR-372 (unknown origin) in presence of 100-fold excess of Escherichia coli tRNA to Kd for 5'-FAM-pre-miR-372 (unknown origin),B,BAO_0000193,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2494670,=,1,0,=,Ratio,,1.0,CHEMBL612545,,Unchecked,,,Ratio,,,1.0
50820,,15683507,CHEMBL3607737,Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) after 4 hrs by fluorescence assay in presence of 100-fold excess of 15-mer DNA,B,BAO_0000034,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2494670,=,1,1,=,Kd,nM,11300.0,CHEMBL612545,,Unchecked,,,Kd,uM,UO_0000065,11.3
50821,,15683518,CHEMBL3607738,Ratio of Kd for 5'-FAM-pre-miR-372 (unknown origin) in presence of 100-fold excess of 15-mer DNA to Kd for 5'-FAM-pre-miR-372 (unknown origin),B,BAO_0000193,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2494670,=,1,0,=,Ratio,,1.0,CHEMBL612545,,Unchecked,,,Ratio,,,1.0
50822,Active,15683529,CHEMBL3607739,Inhibition of pre-miR-372 (unknown origin) cleavage at C27 at 10 to 100 uM after 15 mins by RNase footprinting assay in presence of RNase-V1,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
50823,Active,15683530,CHEMBL3607740,Inhibition of pre-miR-372 (unknown origin) cleavage at U15-G16-G17-A18 at 10 to 100 uM after 15 mins by RNase footprinting assay in presence of RNase-V1,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
50824,Active,15683531,CHEMBL3607741,Inhibition of pre-miR-372 (unknown origin) cleavage at A10-A11 at 10 to 100 uM after 15 mins by RNase footprinting assay in presence of RNase-V1,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
50825,Not Active,15683532,CHEMBL3607742,Inhibition of pre-miR-372 (unknown origin) cleavage at 10 to 100 uM after 15 mins by RNase footprinting assay in presence of RNase-S1,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
50826,Active,15683535,CHEMBL3607745,Inhibition of pre-miR-372 (unknown origin) cleavage at A24 at 1 to 100 uM after 2 hrs by denaturing gel electrophoresis in presence of recombinant Dicer,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
50827,Active,15683537,CHEMBL3607746,Inhibition of pre-miR-372 (unknown origin) cleavage at A42 at 1 to 100 uM after 2 hrs by denaturing gel electrophoresis in presence of recombinant Dicer,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
50828,Active,15683539,CHEMBL3607747,Inhibition of pre-miR-372 (unknown origin) cleavage at U28 at 1 to 100 uM after 2 hrs by denaturing gel electrophoresis in presence of recombinant Dicer,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
50829,,15683541,CHEMBL3607748,Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) assessed as change in total free energy by thermodynamic assay,B,BAO_0001103,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3603759,Bioorg Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2494670,=,1,0,=,Activity,%,70.0,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,70.0
50830,,15718361,CHEMBL3619522,Antimicrobial activity against methicillin-resistant Staphylococcus aureus HEMSA incubated for 20 hrs by serial dilution broth microplate method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3616416,Eur J Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2501611,=,1,1,=,MIC,nM,240000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.24
50831,,15718378,CHEMBL3619523,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 20 hrs by serial dilution broth microplate method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3616416,Eur J Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2501611,=,1,1,=,MIC,nM,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.001
50832,,15718474,CHEMBL3620216,"Resistance index, ratio of MIC for methicillin-resistant Staphylococcus aureus HEMSA to MIC for Staphylococcus aureus ATCC 25923",F,BAO_0000193,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3616416,Eur J Med Chem,2015.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2501611,=,1,0,=,Ratio,,240.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,240.0
50833,,16758114,CHEMBL3861523,Antibacterial activity against Staphylococcus aureus ATCC 25923 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
50834,,16758137,CHEMBL3861524,Antibacterial activity against NorA expressing Staphylococcus aureus 1 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
50835,,16758160,CHEMBL3861525,Antibacterial activity against healthcare-acquired methicillin-resistant Staphylococcus aureus ATCC 33592 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
50836,,16758183,CHEMBL3861526,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
50837,,16758206,CHEMBL3861527,Antibacterial activity against AAC6'-2A expressing Pseudomonas aeruginosa F03 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
50838,,16758229,CHEMBL3861528,Antibacterial activity against MexXY expressing Pseudomonas aeruginosa PA22 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
50839,,16758252,CHEMBL3861529,Antibacterial activity against triABC deficient Pseudomonas aeruginosa PA406 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
50840,,16758275,CHEMBL3861530,Antibacterial activity against Acinetobacter lwoffii ATCC 17925 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.25
50841,,16758298,CHEMBL3861531,Antibacterial activity against APH3'-VIA expressing Acinetobacter lwoffii AI.88-483 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,64.0
50842,,16758321,CHEMBL3861532,Antibacterial activity against Escherichia coli ATCC 25922 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
50843,,16758344,CHEMBL3861533,Antibacterial activity against AAC6'-IB expressing Escherichia coli PAZ505H8101 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
50844,,16758367,CHEMBL3861534,Antibacterial activity against ANT2''-IA expressing Escherichia coli L8058.1 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
50845,,16758390,CHEMBL3861535,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801467,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
50846,Active,16806831,CHEMBL3870158,Binding affinity to poly(rA).(rU) RNA duplex (unknown origin) measured after 5 mins by circular dichroism titration method,B,BAO_0000375,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3868633,Bioorg Med Chem Lett,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2809726,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
50847,Active,16806836,CHEMBL3870155,Binding affinity to poly(rA).(rU) RNA duplex (unknown origin) assessed as change in CD band intensity at 266 nanometer measured after 5 mins by circular dichroism titration method,B,BAO_0000375,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3868633,Bioorg Med Chem Lett,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2809726,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
50848,,16806849,CHEMBL3870152,Inhibition of ethidium bromide binding to r(CGCAAAUUUGCG)2 RNA (unknown origin) at 1:1 ratio of ligand:RNA measured after 5 mins by fluorescent intercalator displacement assay relative to control,B,BAO_0000201,BAO_0000019,assay format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3868633,Bioorg Med Chem Lett,2016.0,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2809726,=,1,1,=,Inhibition,%,20.4,CHEMBL612545,,Unchecked,,,INH,%,UO_0000187,20.4
50849,See Activity_Supp For Individual Animal Data,17352396,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALT,U.L-1,33.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,ALANINE AMINOTRANSFERASE,u/L,,33.2
50850,See Activity_Supp For Individual Animal Data,17352403,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,ALB,ug.mL-1,37400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,ALBUMIN,G/DL,UO_0000274,3.74
50851,See Activity_Supp For Individual Animal Data,17352410,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALP,U.L-1,318.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,ALKALINE PHOSPHATASE,u/L,,318.0
50852,See Activity_Supp For Individual Animal Data,17352417,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,AST,U.L-1,78.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,ASPARTATE AMINOTRANSFERASE,u/L,,78.6
50853,See Activity_Supp For Individual Animal Data,17352424,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BUN,ug.mL-1,60.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,6.0
50854,See Activity_Supp For Individual Animal Data,17352431,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CHLORIDE,mEq.L-1,108.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,CHLORIDE,MEQ/L,,108.4
50855,See Activity_Supp For Individual Animal Data,17352438,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CHOL,ug.mL-1,630.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,CHOLESTEROL,mg/dL,UO_0000274,63.0
50856,See Activity_Supp For Individual Animal Data,17352445,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CK,U.L-1,251.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,CREATINE PHOSPHOKINASE,u/L,,251.0
50857,See Activity_Supp For Individual Animal Data,17352452,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CREAT,ug.mL-1,1.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,CREATININE,mg/dL,UO_0000274,0.18
50858,See Activity_Supp For Individual Animal Data,17352459,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,GLUC,ug.mL-1,1256.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,GLUCOSE,mg/dL,UO_0000274,125.6
50859,See Activity_Supp For Individual Animal Data,17352466,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PHOS,ug.mL-1,120.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,PHOSPHORUS,mg/dL,UO_0000274,12.06
50860,See Activity_Supp For Individual Animal Data,17352473,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,POTASSIUM,mEq.L-1,5.92,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,POTASSIUM,MEQ/L,,5.92
50861,See Activity_Supp For Individual Animal Data,17352480,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,SODIUM,mEq.L-1,146.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,SODIUM,MEQ/L,,146.8
50862,See Activity_Supp For Individual Animal Data,17352487,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BILI,ug.mL-1,1.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.16
50863,See Activity_Supp For Individual Animal Data,17352494,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PROT,ug.mL-1,60600.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,TOTAL PROTEIN,G/DL,UO_0000274,6.06
50864,See Activity_Supp For Individual Animal Data,17352501,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,BASOLE,%,0.32,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,BASOPHIL,%,UO_0000187,0.32
50865,See Activity_Supp For Individual Animal Data,17352508,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,EOSLE,%,0.58,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,EOSINOPHIL,%,UO_0000187,0.58
50866,See Activity_Supp For Individual Animal Data,17352515,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,RBC,cells.uL-1,7260000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,ERYTHROCYTE COUNT,x10E6/uL,,7.26
50867,See Activity_Supp For Individual Animal Data,17352522,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,HCT,%,46.94,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,HEMATOCRIT,%,UO_0000187,46.94
50868,See Activity_Supp For Individual Animal Data,17352529,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,HGB,ug.mL-1,149000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,HEMOGLOBIN,G/DL,UO_0000274,14.9
50869,See Activity_Supp For Individual Animal Data,17352536,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,WBC,cells.uL-1,8690.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,LEUKOCYTE COUNT,x10E3/uL,,8.69
50870,See Activity_Supp For Individual Animal Data,17352543,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,LYMLE,%,81.52,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,LYMPHOCYTE,%,UO_0000187,81.52
50871,See Activity_Supp For Individual Animal Data,17352550,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCH,pg,20.58,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,20.58
50872,See Activity_Supp For Individual Animal Data,17352557,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,MCHC,ug.mL-1,318000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,31.8
50873,See Activity_Supp For Individual Animal Data,17352564,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCV,fL,64.68,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,MEAN CORPUSCULAR VOLUME,FL,,64.68
50874,See Activity_Supp For Individual Animal Data,17352571,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,MONOLE,%,2.16,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,MONOCYTE,%,UO_0000187,2.16
50875,See Activity_Supp For Individual Animal Data,17352578,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,NEUTLE,%,13.88,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,NEUTROPHIL,%,UO_0000187,13.88
50876,See Activity_Supp For Individual Animal Data,17352585,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,PLAT,cells.uL-1,1531200.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10082.0,PLATELET COUNT,x10E3/uL,,1531.2
50877,See Activity_Supp For Individual Animal Data,17352592,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALT,U.L-1,28.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,ALANINE AMINOTRANSFERASE,u/L,,28.6
50878,See Activity_Supp For Individual Animal Data,17352599,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,ALB,ug.mL-1,39400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,ALBUMIN,G/DL,UO_0000274,3.94
50879,See Activity_Supp For Individual Animal Data,17352606,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALP,U.L-1,254.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,ALKALINE PHOSPHATASE,u/L,,254.6
50880,See Activity_Supp For Individual Animal Data,17352613,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,AST,U.L-1,67.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,ASPARTATE AMINOTRANSFERASE,u/L,,67.8
50881,See Activity_Supp For Individual Animal Data,17352620,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BUN,ug.mL-1,104.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,10.4
50882,See Activity_Supp For Individual Animal Data,17352627,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CHLORIDE,mEq.L-1,104.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,CHLORIDE,MEQ/L,,104.6
50883,See Activity_Supp For Individual Animal Data,17352634,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CHOL,ug.mL-1,576.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,CHOLESTEROL,mg/dL,UO_0000274,57.6
50884,See Activity_Supp For Individual Animal Data,17352641,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CK,U.L-1,224.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,CREATINE PHOSPHOKINASE,u/L,,224.8
50885,See Activity_Supp For Individual Animal Data,17352648,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CREAT,ug.mL-1,4.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,CREATININE,mg/dL,UO_0000274,0.4
50886,See Activity_Supp For Individual Animal Data,17352655,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,GLUC,ug.mL-1,1406.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,GLUCOSE,mg/dL,UO_0000274,140.6
50887,See Activity_Supp For Individual Animal Data,17352662,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PHOS,ug.mL-1,106.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,PHOSPHORUS,mg/dL,UO_0000274,10.66
50888,See Activity_Supp For Individual Animal Data,17352669,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,POTASSIUM,mEq.L-1,6.58,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,POTASSIUM,MEQ/L,,6.58
50889,See Activity_Supp For Individual Animal Data,17352676,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,SODIUM,mEq.L-1,148.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,SODIUM,MEQ/L,,148.6
50890,See Activity_Supp For Individual Animal Data,17352683,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BILI,ug.mL-1,2.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.24
50891,See Activity_Supp For Individual Animal Data,17352690,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PROT,ug.mL-1,66400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,TOTAL PROTEIN,G/DL,UO_0000274,6.64
50892,See Activity_Supp For Individual Animal Data,17352697,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,BASOLE,%,0.42,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,BASOPHIL,%,UO_0000187,0.42
50893,See Activity_Supp For Individual Animal Data,17352704,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,EOSLE,%,0.58,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,EOSINOPHIL,%,UO_0000187,0.58
50894,See Activity_Supp For Individual Animal Data,17352711,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,RBC,cells.uL-1,8060000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,ERYTHROCYTE COUNT,x10E6/uL,,8.06
50895,See Activity_Supp For Individual Animal Data,17352718,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,HCT,%,48.44,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,HEMATOCRIT,%,UO_0000187,48.44
50896,See Activity_Supp For Individual Animal Data,17352725,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,HGB,ug.mL-1,163400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,HEMOGLOBIN,G/DL,UO_0000274,16.34
50897,See Activity_Supp For Individual Animal Data,17352732,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,WBC,cells.uL-1,13040.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,LEUKOCYTE COUNT,x10E3/uL,,13.04
50898,See Activity_Supp For Individual Animal Data,17352739,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,LYMLE,%,85.12,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,LYMPHOCYTE,%,UO_0000187,85.12
50899,See Activity_Supp For Individual Animal Data,17352746,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCH,pg,20.26,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,20.26
50900,See Activity_Supp For Individual Animal Data,17352753,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,MCHC,ug.mL-1,337400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,33.74
50901,See Activity_Supp For Individual Animal Data,17352760,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCV,fL,60.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,MEAN CORPUSCULAR VOLUME,FL,,60.1
50902,See Activity_Supp For Individual Animal Data,17352767,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,MONOLE,%,1.44,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,MONOCYTE,%,UO_0000187,1.44
50903,See Activity_Supp For Individual Animal Data,17352774,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,NEUTLE,%,11.28,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,NEUTROPHIL,%,UO_0000187,11.28
50904,See Activity_Supp For Individual Animal Data,17352781,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,PLAT,cells.uL-1,1226000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10089.0,PLATELET COUNT,x10E3/uL,,1226.0
50905,See Activity_Supp For Individual Animal Data,17353008,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALT,U.L-1,29.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,ALANINE AMINOTRANSFERASE,u/L,,29.0
50906,See Activity_Supp For Individual Animal Data,17353009,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,ALB,ug.mL-1,37400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,ALBUMIN,G/DL,UO_0000274,3.74
50907,See Activity_Supp For Individual Animal Data,17353010,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALP,U.L-1,336.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,ALKALINE PHOSPHATASE,u/L,,336.0
50908,See Activity_Supp For Individual Animal Data,17353011,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,AST,U.L-1,73.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,ASPARTATE AMINOTRANSFERASE,u/L,,73.8
50909,See Activity_Supp For Individual Animal Data,17353012,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BUN,ug.mL-1,66.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,6.6
50910,See Activity_Supp For Individual Animal Data,17353013,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CHLORIDE,mEq.L-1,109.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,CHLORIDE,MEQ/L,,109.6
50911,See Activity_Supp For Individual Animal Data,17353014,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CHOL,ug.mL-1,606.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,CHOLESTEROL,mg/dL,UO_0000274,60.6
50912,See Activity_Supp For Individual Animal Data,17353015,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CK,U.L-1,307.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,CREATINE PHOSPHOKINASE,u/L,,307.0
50913,See Activity_Supp For Individual Animal Data,17353016,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CREAT,ug.mL-1,2.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,CREATININE,mg/dL,UO_0000274,0.28
50914,See Activity_Supp For Individual Animal Data,17353017,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,GLUC,ug.mL-1,1286.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,GLUCOSE,mg/dL,UO_0000274,128.6
50915,See Activity_Supp For Individual Animal Data,17353018,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PHOS,ug.mL-1,138.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,PHOSPHORUS,mg/dL,UO_0000274,13.88
50916,See Activity_Supp For Individual Animal Data,17353019,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,POTASSIUM,mEq.L-1,6.96,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,POTASSIUM,MEQ/L,,6.96
50917,See Activity_Supp For Individual Animal Data,17353020,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,SODIUM,mEq.L-1,151.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,SODIUM,MEQ/L,,151.8
50918,See Activity_Supp For Individual Animal Data,17353021,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BILI,ug.mL-1,1.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.16
50919,See Activity_Supp For Individual Animal Data,17353022,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PROT,ug.mL-1,62200.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,TOTAL PROTEIN,G/DL,UO_0000274,6.22
50920,See Activity_Supp For Individual Animal Data,17353023,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,BASOLE,%,0.36,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,BASOPHIL,%,UO_0000187,0.36
50921,See Activity_Supp For Individual Animal Data,17353024,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,EOSLE,%,0.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,EOSINOPHIL,%,UO_0000187,0.6
50922,See Activity_Supp For Individual Animal Data,17353025,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,RBC,cells.uL-1,7450000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,ERYTHROCYTE COUNT,x10E6/uL,,7.45
50923,See Activity_Supp For Individual Animal Data,17353026,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,HCT,%,49.44,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,HEMATOCRIT,%,UO_0000187,49.44
50924,See Activity_Supp For Individual Animal Data,17353027,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,HGB,ug.mL-1,156000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,HEMOGLOBIN,G/DL,UO_0000274,15.6
50925,See Activity_Supp For Individual Animal Data,17353028,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,WBC,cells.uL-1,6840.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,LEUKOCYTE COUNT,x10E3/uL,,6.84
50926,See Activity_Supp For Individual Animal Data,17353029,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,LYMLE,%,82.08,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,LYMPHOCYTE,%,UO_0000187,82.08
50927,See Activity_Supp For Individual Animal Data,17353030,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCH,pg,20.94,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,20.94
50928,See Activity_Supp For Individual Animal Data,17353031,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,MCHC,ug.mL-1,315800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,31.58
50929,See Activity_Supp For Individual Animal Data,17353032,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCV,fL,66.34,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,MEAN CORPUSCULAR VOLUME,FL,,66.34
50930,See Activity_Supp For Individual Animal Data,17353033,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,MONOLE,%,1.68,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,MONOCYTE,%,UO_0000187,1.68
50931,See Activity_Supp For Individual Animal Data,17353034,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,NEUTLE,%,14.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,NEUTROPHIL,%,UO_0000187,14.3
50932,See Activity_Supp For Individual Animal Data,17353035,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,PLAT,cells.uL-1,1274600.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10100.0,PLATELET COUNT,x10E3/uL,,1274.6
50933,See Activity_Supp For Individual Animal Data,17353036,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALT,U.L-1,26.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,ALANINE AMINOTRANSFERASE,u/L,,26.9
50934,See Activity_Supp For Individual Animal Data,17353037,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,ALB,ug.mL-1,38500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,ALBUMIN,G/DL,UO_0000274,3.85
50935,See Activity_Supp For Individual Animal Data,17353038,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALP,U.L-1,200.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,ALKALINE PHOSPHATASE,u/L,,200.9
50936,See Activity_Supp For Individual Animal Data,17353039,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,AST,U.L-1,62.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,ASPARTATE AMINOTRANSFERASE,u/L,,62.4
50937,See Activity_Supp For Individual Animal Data,17353040,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BUN,ug.mL-1,110.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,11.0
50938,See Activity_Supp For Individual Animal Data,17353041,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CHLORIDE,mEq.L-1,107.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,CHLORIDE,MEQ/L,,107.1
50939,See Activity_Supp For Individual Animal Data,17353042,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CHOL,ug.mL-1,545.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,CHOLESTEROL,mg/dL,UO_0000274,54.5
50940,See Activity_Supp For Individual Animal Data,17353043,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CK,U.L-1,177.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,CREATINE PHOSPHOKINASE,u/L,,177.2
50941,See Activity_Supp For Individual Animal Data,17353044,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CREAT,ug.mL-1,3.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,CREATININE,mg/dL,UO_0000274,0.38
50942,See Activity_Supp For Individual Animal Data,17353045,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,GLUC,ug.mL-1,1352.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,GLUCOSE,mg/dL,UO_0000274,135.2
50943,See Activity_Supp For Individual Animal Data,17353046,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PHOS,ug.mL-1,111.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,PHOSPHORUS,mg/dL,UO_0000274,11.16
50944,See Activity_Supp For Individual Animal Data,17353047,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,POTASSIUM,mEq.L-1,6.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,POTASSIUM,MEQ/L,,6.5
50945,See Activity_Supp For Individual Animal Data,17353048,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,SODIUM,mEq.L-1,151.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,SODIUM,MEQ/L,,151.5
50946,See Activity_Supp For Individual Animal Data,17353049,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BILI,ug.mL-1,2.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.22
50947,See Activity_Supp For Individual Animal Data,17353050,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PROT,ug.mL-1,65200.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,TOTAL PROTEIN,G/DL,UO_0000274,6.52
50948,See Activity_Supp For Individual Animal Data,17353051,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,BASOLE,%,0.48,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,BASOPHIL,%,UO_0000187,0.48
50949,See Activity_Supp For Individual Animal Data,17353052,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,EOSLE,%,0.51,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,EOSINOPHIL,%,UO_0000187,0.51
50950,See Activity_Supp For Individual Animal Data,17353053,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,RBC,cells.uL-1,8010000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,ERYTHROCYTE COUNT,x10E6/uL,,8.01
50951,See Activity_Supp For Individual Animal Data,17353054,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,HCT,%,48.92,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,HEMATOCRIT,%,UO_0000187,48.92
50952,See Activity_Supp For Individual Animal Data,17353055,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,HGB,ug.mL-1,158800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,HEMOGLOBIN,G/DL,UO_0000274,15.88
50953,See Activity_Supp For Individual Animal Data,17353056,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,WBC,cells.uL-1,12820.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,LEUKOCYTE COUNT,x10E3/uL,,12.82
50954,See Activity_Supp For Individual Animal Data,17353057,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,LYMLE,%,83.46,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,LYMPHOCYTE,%,UO_0000187,83.46
50955,See Activity_Supp For Individual Animal Data,17353058,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCH,pg,19.85,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,19.85
50956,See Activity_Supp For Individual Animal Data,17353059,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,MCHC,ug.mL-1,324700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,32.47
50957,See Activity_Supp For Individual Animal Data,17353060,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCV,fL,61.12,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,MEAN CORPUSCULAR VOLUME,FL,,61.12
50958,See Activity_Supp For Individual Animal Data,17353061,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,MONOLE,%,1.54,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,MONOCYTE,%,UO_0000187,1.54
50959,See Activity_Supp For Individual Animal Data,17353062,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,NEUTLE,%,12.95,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,NEUTROPHIL,%,UO_0000187,12.95
50960,See Activity_Supp For Individual Animal Data,17353063,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,PLAT,cells.uL-1,1208100.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10101.0,PLATELET COUNT,x10E3/uL,,1208.1
50961,See Activity_Supp For Individual Animal Data,17378313,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALT,U.L-1,76.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ALANINE AMINOTRANSFERASE,u/L,,76.67
50962,See Activity_Supp For Individual Animal Data,17378323,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,ALB,ug.mL-1,39300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ALBUMIN,G/DL,UO_0000274,3.93
50963,See Activity_Supp For Individual Animal Data,17378333,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALP,U.L-1,317.17,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ALKALINE PHOSPHATASE,u/L,,317.17
50964,See Activity_Supp For Individual Animal Data,17378343,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,AST,U.L-1,81.17,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ASPARTATE AMINOTRANSFERASE,u/L,,81.17
50965,See Activity_Supp For Individual Animal Data,17378353,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BUN,ug.mL-1,123.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,12.33
50966,See Activity_Supp For Individual Animal Data,17378363,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/Nanomolar,2834716,=,15,1,=,CO2,nM,31170000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,CARBON DIOXIDE,MMOL/L,UO_0000065,31.17
50967,See Activity_Supp For Individual Animal Data,17378373,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CHLORIDE,mEq.L-1,98.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,CHLORIDE,MEQ/L,,98.33
50968,See Activity_Supp For Individual Animal Data,17378383,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CHOL,ug.mL-1,671.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,CHOLESTEROL,mg/dL,UO_0000274,67.17
50969,See Activity_Supp For Individual Animal Data,17378393,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,CK,U.L-1,312.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,CREATINE PHOSPHOKINASE,u/L,,312.33
50970,See Activity_Supp For Individual Animal Data,17378403,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,CREAT,ug.mL-1,1.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,CREATININE,mg/dL,UO_0000274,0.19
50971,See Activity_Supp For Individual Animal Data,17378413,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,GLUC,ug.mL-1,1655.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,GLUCOSE,mg/dL,UO_0000274,165.5
50972,See Activity_Supp For Individual Animal Data,17378423,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,LDH,U.L-1,94.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,LACTATE DEHYDROGENASE,u/L,,94.5
50973,See Activity_Supp For Individual Animal Data,17378433,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,LIPASE,U.L-1,9.83,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,LIPASE,u/L,,9.83
50974,See Activity_Supp For Individual Animal Data,17378443,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PHOS,ug.mL-1,101.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,PHOSPHORUS,mg/dL,UO_0000274,10.1
50975,See Activity_Supp For Individual Animal Data,17378453,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,POTASSIUM,mEq.L-1,5.16,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,POTASSIUM,MEQ/L,,5.16
50976,See Activity_Supp For Individual Animal Data,17378463,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,SODIUM,mEq.L-1,143.02,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,SODIUM,MEQ/L,,143.02
50977,See Activity_Supp For Individual Animal Data,17378473,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,BILI,ug.mL-1,2.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.2
50978,See Activity_Supp For Individual Animal Data,17378483,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,PROT,ug.mL-1,58800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,TOTAL PROTEIN,G/DL,UO_0000274,5.88
50979,See Activity_Supp For Individual Animal Data,17378493,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,URATE,ug.mL-1,6.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,URIC ACID,mg/dL,UO_0000274,0.68
50980,See Activity_Supp For Individual Animal Data,17378503,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,BASO,cells.uL-1,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.0
50981,See Activity_Supp For Individual Animal Data,17378513,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,EOS,cells.uL-1,33.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,33.0
50982,See Activity_Supp For Individual Animal Data,17378523,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,LYM,cells.uL-1,9048.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,9048.5
50983,See Activity_Supp For Individual Animal Data,17378533,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MONO,cells.uL-1,80.17,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ABSOLUTE MONOCYTE,CELLS/uL,,80.17
50984,See Activity_Supp For Individual Animal Data,17378543,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,NEUTSG,cells.uL-1,1521.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,1521.67
50985,See Activity_Supp For Individual Animal Data,17378553,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,BASOLE,%,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,BASOPHIL,%,UO_0000187,0.0
50986,See Activity_Supp For Individual Animal Data,17378563,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,EOSLE,%,0.17,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,EOSINOPHIL,%,UO_0000187,0.17
50987,See Activity_Supp For Individual Animal Data,17378573,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,RBC,cells.uL-1,5460000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,ERYTHROCYTE COUNT,x10E6/uL,,5.46
50988,See Activity_Supp For Individual Animal Data,17378583,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,HCT,%,32.87,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,HEMATOCRIT,%,UO_0000187,32.87
50989,See Activity_Supp For Individual Animal Data,17378593,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,HGB,ug.mL-1,129500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,HEMOGLOBIN,G/DL,UO_0000274,12.95
50990,See Activity_Supp For Individual Animal Data,17378603,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,WBC,cells.uL-1,10680.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,LEUKOCYTE COUNT,x10E3/uL,,10.68
50991,See Activity_Supp For Individual Animal Data,17378613,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,LYMLE,%,86.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,LYMPHOCYTE,%,UO_0000187,86.67
50992,See Activity_Supp For Individual Animal Data,17378623,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCH,pg,23.72,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,23.72
50993,See Activity_Supp For Individual Animal Data,17378633,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834716,=,15,1,=,MCHC,ug.mL-1,394000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,39.4
50994,See Activity_Supp For Individual Animal Data,17378643,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,MCV,fL,60.18,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,MEAN CORPUSCULAR VOLUME,FL,,60.18
50995,See Activity_Supp For Individual Animal Data,17378653,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,MONOLE,%,0.83,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,MONOCYTE,%,UO_0000187,0.83
50996,See Activity_Supp For Individual Animal Data,17378663,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,http://qudt.org/vocab/unit#Percent,2834716,=,15,1,=,NEUTLE,%,12.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,NEUTROPHIL,%,UO_0000187,12.33
50997,See Activity_Supp For Individual Animal Data,17378673,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,RBCNUC,/100WBC,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,NUCLEATED RED BLOOD CELLS,/100WBC,,0.0
50998,See Activity_Supp For Individual Animal Data,17378683,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,PLAT,cells.uL-1,1211330.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10805.0,PLATELET COUNT,x10E3/uL,,1211.33
50999,See Activity_Supp For Individual Animal Data,17378693,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,CHEMBL3885881,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,0,,2834716,=,15,1,=,ALT,U.L-1,93.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10815.0,ALANINE AMINOTRANSFERASE,u/L,,93.67
